<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN""http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html><head><title>Patent US5681946 - Precipitating polymers - Google Patents</title><script>(function(){(function(){function e(a){this.t={};this.tick=function(a,c,b){var d=void 0!=b?b:(new Date).getTime();this.t[a]=[d,c];if(void 0==b)try{window.console.timeStamp("CSI/"+a)}catch(e){}};this.tick("start",null,a)}var a;window.performance&&(a=window.performance.timing);var f=a?new e(a.responseStart):new e;window.jstiming={Timer:e,load:f};if(a){var c=a.navigationStart,d=a.responseStart;0<c&&d>=c&&(window.jstiming.srt=d-c)}if(a){var b=window.jstiming.load;0<c&&d>=c&&(b.tick("_wtsrt",void 0,c),b.tick("wtsrt_",
"_wtsrt",d),b.tick("tbsd_","wtsrt_"))}try{a=null,window.chrome&&window.chrome.csi&&(a=Math.floor(window.chrome.csi().pageT),b&&0<c&&(b.tick("_tbnd",void 0,window.chrome.csi().startE),b.tick("tbnd_","_tbnd",c))),null==a&&window.gtbExternal&&(a=window.gtbExternal.pageT()),null==a&&window.external&&(a=window.external.pageT,b&&0<c&&(b.tick("_tbnd",void 0,window.external.startE),b.tick("tbnd_","_tbnd",c))),a&&(window.jstiming.pt=a)}catch(g){}})();})();
</script><link rel="stylesheet" href="/patents/css/_8a2b04e7bf975d5171d8e4c0b6365c7a/kl_intl_patents_bundle.css" type="text/css" /><script src="/books/javascript/atb_8a2b04e7bf975d5171d8e4c0b6365c7a__en.js"></script><script>function googleTranslateElementInit() {new google.translate.TranslateElement({pageLanguage: "en",gaTrack: true,gaId: "UA-27188110-1",multilanguagePage: true});}</script><script src="//translate.google.com/translate_a/element.js?cb=googleTranslateElementInit"></script><meta name="DC.type" content="Patent"><meta name="DC.title" content="Precipitating polymers"><meta name="DC.contributor" content="Michael Alan Reeve" scheme="inventor"><meta name="DC.contributor" content="Amersham International Plc" scheme="assignee"><meta name="DC.date" content="1996-4-3" scheme="dateSubmitted"><meta name="DC.description" content="A method of recovering a biopolymer from solution involves the use of magnetically attractable beads which do not specifically bind the polymer. The beads are suspended in the solution. Then the polymer is precipitated out of solution and becomes non-specifically associated with the beads. When the beads are magnetically drawn down, the polymer is drawn down with them. The polymer can subsequently be resolubilized and separated from the beads."><meta name="DC.date" content="1997-10-28" scheme="issued"><meta name="DC.relation" content="BE:686243" scheme="references"><meta name="DC.relation" content="EP:0162819:A1" scheme="references"><meta name="DC.relation" content="EP:0281390:A2" scheme="references"><meta name="DC.relation" content="JP:40408934" scheme="references"><meta name="DC.relation" content="US:3470057" scheme="references"><meta name="DC.relation" content="US:4001197" scheme="references"><meta name="DC.relation" content="US:4672040" scheme="references"><meta name="DC.relation" content="US:4710472" scheme="references"><meta name="DC.relation" content="US:5091206" scheme="references"><meta name="DC.relation" content="US:5108933" scheme="references"><meta name="DC.relation" content="US:5422279" scheme="references"><meta name="DC.relation" content="US:5441635" scheme="references"><meta name="DC.relation" content="US:5484701" scheme="references"><meta name="DC.relation" content="US:5508164" scheme="references"><meta name="DC.relation" content="US:5512439" scheme="references"><meta name="DC.relation" content="US:5523231" scheme="references"><meta name="DC.relation" content="US:RE35340" scheme="references"><meta name="DC.relation" content="WO:1984001503:A1" scheme="references"><meta name="citation_reference" content="Bitton et al., &quot;Removal of Escherichia coli Bacteriophage T7 by Magnetic Filtration,&quot; Water Res., 8(8), 549-551 (1974); Chem. Abstr., 82, p. 278, Abstr. No. 115,953y (1974); only Abstract supplied."><meta name="citation_reference" content="Bitton et al., Removal of Escherichia coli Bacteriophage T7 by Magnetic Filtration, Water Res., 8(8), 549 551 (1974); Chem. Abstr., 82, p. 278, Abstr. No. 115,953y (1974); only Abstract supplied."><meta name="citation_reference" content="Flygare et al., &quot;Magnetic Aqueous Two-phase Separation in Preparative Applications,&quot; Enzyme Microb. Biotech., 12(2), 95-103 (1990); Chem. Abstr., 112, p. 606, Abstr. No. 96880s (1990); only Abstract supplied."><meta name="citation_reference" content="Flygare et al., Magnetic Aqueous Two phase Separation in Preparative Applications, Enzyme Microb. Biotech., 12(2), 95 103 (1990); Chem. Abstr., 112, p. 606, Abstr. No. 96880s (1990); only Abstract supplied."><meta name="citation_reference" content="Munro et al., &quot;Magnetic Seeding to Aid Recovery of Biological Precipitates,&quot; Biotechnol. Letters, 3(6), 297-302 (1981); Chem. Abstr., 95, pp. 394-395, Abstr. No. 76474q (1981); both Abstract and publication supplied."><meta name="citation_reference" content="Munro et al., Magnetic Seeding to Aid Recovery of Biological Precipitates, Biotechnol. Letters, 3(6), 297 302 (1981); Chem. Abstr., 95, pp. 394 395, Abstr. No. 76474q (1981); both Abstract and publication supplied."><meta name="citation_reference" content="Warren, &quot;New Purification Procedure for Biological Vaccines (Adsorption on Magnetic Iron Oxides),&quot; Immunization Jap. Encephalitis Conf., Hammon (ed.), Williams &amp; Wilkins, Baltimore, MD, 1971, pp. 152-154; Chem. Abstr., 77, p. 308, Abstr. No. 92767w (1972); only Abstract supplied."><meta name="citation_reference" content="Warren, New Purification Procedure for Biological Vaccines (Adsorption on Magnetic Iron Oxides), Immunization Jap. Encephalitis Conf., Hammon (ed.), Williams &amp; Wilkins, Baltimore, MD, 1971, pp. 152 154; Chem. Abstr., 77, p. 308, Abstr. No. 92767w (1972); only Abstract supplied."><meta name="citation_patent_number" content="US:5681946"><meta name="citation_patent_application_number" content="US:08/627,097"><link rel="canonical" href="http://www.google.com/patents/US5681946"/><meta property="og:url" content="http://www.google.com/patents/US5681946"/><meta name="title" content="Patent US5681946 - Precipitating polymers"/><meta name="description" content="A method of recovering a biopolymer from solution involves the use of magnetically attractable beads which do not specifically bind the polymer. The beads are suspended in the solution. Then the polymer is precipitated out of solution and becomes non-specifically associated with the beads. When the beads are magnetically drawn down, the polymer is drawn down with them. The polymer can subsequently be resolubilized and separated from the beads."/><meta property="og:title" content="Patent US5681946 - Precipitating polymers"/><meta property="og:type" content="book"/><meta property="og:site_name" content="Google Books"/><meta property="og:image" content="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"/><link rel="image_src" href="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"/><script>(function(){try{var aa=function(a,b,c,d){d=d||{};d._sn=["cfg",b,c].join(".");window.gbar.logger.ml(a,d)};var g=window.gbar=window.gbar||{},l=window.gbar.i=window.gbar.i||{},m={},n;function _tvn(a,b){var c=parseInt(a,10);return isNaN(c)?b:c}function _tvf(a,b){var c=parseFloat(a);return isNaN(c)?b:c}function _tvv(a){return!!a}function p(a,b,c){(c||g)[a]=b}g.bv={n:_tvn("2",0),r:"",f:".67.",e:"0",m:_tvn("0",1)};
function q(a,b,c){var d="on"+b;if(a.addEventListener)a.addEventListener(b,c,!1);else if(a.attachEvent)a.attachEvent(d,c);else{var f=a[d];a[d]=function(){var a=f.apply(this,arguments),b=c.apply(this,arguments);return void 0==a?b:void 0==b?a:b&&a}}}var s=function(a){return function(){return g.bv.m==a}},ba=s(1),ca=s(2);p("sb",ba);p("kn",ca);l.a=_tvv;l.b=_tvf;l.c=_tvn;l.i=aa;var da=window.gbar.i.i;var t,u,v,w;function ea(a){v=a}function fa(a){var b;if(b=v&&window.encodeURIComponent)b=a.href,b=!b.match(/^http[s]?:\/\/accounts\.google\.[^/]*\/ClearSID/i)&&!b.match(/^http[s]?:\/\/[^/]*\/accounts\/ClearSID/i);if(b=b&&encodeURIComponent(v()))a.href=a.href.replace(/([?&]continue=)[^&]*/,"$1"+b)}function ga(a){window.gApplication&&(a.href=window.gApplication.getTabUrl(a.href))}
function ha(a){var b=document.forms[0].q,c=window.encodeURIComponent&&b&&b.value,b=b&&b.placeholder;c&&c!=b&&(a.href=a.href.replace(/([?&])q=[^&]*|$/,function(a,b){return(b||"&")+"q="+encodeURIComponent(c)}))}n=l.a("")?ga:ha;
function x(a,b,c,d,f,e){var h=document.getElementById(a);if(h){var k=h.style;k.left=d?"auto":b+"px";k.right=d?b+"px":"auto";k.top=c+"px";k.visibility=u?"hidden":"visible";f&&e?(k.width=f+"px",k.height=e+"px"):(x(t,b,c,d,h.offsetWidth,h.offsetHeight),u=u?"":a)}}
var y=[],ia=function(a,b){y.push(b)},ja=function(a){a=a||window.event;var b=a.target||a.srcElement;a.cancelBubble=!0;null==t&&(a=document.createElement(Array.every||window.createPopup?"iframe":"div"),a.frameBorder="0",t=a.id="gbs",a.src="javascript:''",b.parentNode.appendChild(a),q(document,"click",z));var c=b,b=0;"gb3"!=c.className&&(c=c.parentNode);a=c.getAttribute("aria-owns")||"gbi";var d=c.offsetWidth,f=20<c.offsetTop?46:24;document.getElementById("tphdr")&&(f-=3);var e=!1;do b+=c.offsetLeft||
0;while(c=c.offsetParent);var c=(document.documentElement.clientWidth||document.body.clientWidth)-b-d,h,d=document.body,k=document.defaultView;k&&k.getComputedStyle?(d=k.getComputedStyle(d,""))&&(h=d.direction):h=d.currentStyle?d.currentStyle.direction:d.style.direction;h="rtl"==h;if("gbi"==a){for(d=0;k=y[d++];)k();A(null,window.navExtra);h&&(b=c,e=!0)}else h||(b=c,e=!0);u!=a&&z();x(a,b,f,e)},z=function(){u&&x(u,0,0)},A=function(a,b){var c,d=document.getElementById("gbi"),f=a;f||(f=d.firstChild);
for(;b&&(c=b.pop());){var e=d,h=c,k=f;w||(w="gb2");e.insertBefore(h,k).className=w}},ka=function(a,b,c){if((b=document.getElementById(b))&&a){a.className="gb4";var d=document.createElement("span");d.appendChild(a);d.appendChild(document.createTextNode(" | "));d.id=c;b.appendChild(d)}},la=function(){return document.getElementById("gb_70")},ma=function(){return!!u};p("qs",n);p("setContinueCb",ea);p("pc",fa);p("tg",ja);p("close",z);p("addLink",ka);p("almm",A);p("si",la);p("adh",ia);p("op",ma);var B=function(){},C=function(){},F=function(a){var b=new Image,c=D;b.onerror=b.onload=b.onabort=function(){try{delete E[c]}catch(a){}};E[c]=b;b.src=a;D=c+1},E=[],D=0;p("logger",{il:C,ml:B,log:F});var G=window.gbar.logger;var H={},na={},I=[],oa=l.b("0.1",.1),pa=l.a("1",!0),qa=function(a,b){I.push([a,b])},ra=function(a,b){H[a]=b},sa=function(a){return a in H},J={},K=function(a,b){J[a]||(J[a]=[]);J[a].push(b)},ta=function(a){K("m",a)},L=function(a,b){var c=document.createElement("script");c.src=a;c.async=pa;Math.random()<oa&&(c.onerror=function(){c.onerror=null;B(Error("Bundle load failed: name="+(b||"UNK")+" url="+a))});(document.getElementById("xjsc")||document.getElementsByTagName("body")[0]||
document.getElementsByTagName("head")[0]).appendChild(c)},N=function(a){for(var b=0,c;(c=I[b])&&c[0]!=a;++b);!c||c[1].l||c[1].s||(c[1].s=!0,M(2,a),c[1].url&&L(c[1].url,a),c[1].libs&&m.d&&m.d(c[1].libs))},O=function(a){K("gc",a)},P=null,ua=function(a){P=a},M=function(a,b,c){if(P){a={t:a,b:b};if(c)for(var d in c)a[d]=c[d];try{P(a)}catch(f){}}};p("mdc",H);p("mdi",na);p("bnc",I);p("qGC",O);p("qm",ta);p("qd",J);p("lb",N);p("mcf",ra);p("bcf",qa);p("aq",K);p("mdd","");p("has",sa);
p("trh",ua);p("tev",M);var Q=l.b("0.1",.001),R=0;
function _mlToken(a,b){try{if(1>R){R++;var c,d=a,f=b||{},e=encodeURIComponent,h=["//www.google.com/gen_204?atyp=i&zx=",(new Date).getTime(),"&jexpid=",e("17483"),"&srcpg=",e("prop=22"),"&jsr=",Math.round(1/Q),"&ogev=",e("_qTtU-ijN8iZogT8uoCYDw"),"&ogf=",g.bv.f,"&ogrp=",e("1"),"&ogv=",e("1407723702.0"),"&oggv="+e("es_plusone_gc_20140723.0_p0"),"&ogd=",e("com"),"&ogc=",e("NZL"),"&ogl=",e("en")];f._sn&&(f._sn="og."+
f._sn);for(var k in f)h.push("&"),h.push(e(k)),h.push("="),h.push(e(f[k]));h.push("&emsg=");h.push(e(d.name+":"+d.message));var r=h.join("");S(r)&&(r=r.substr(0,2E3));c=r;var Aa=window.gbar.logger._aem(a,c);F(Aa)}}catch(Na){}}var S=function(a){return 2E3<=a.length},va=function(a,b){return b};function T(a){B=a;p("_itl",S,G);p("_aem",va,G);p("ml",B,G);a={};H.er=a}l.a("")?T(function(a){throw a;}):l.a("1")&&Math.random()<Q&&T(_mlToken);I.push(["m",{url:"//ssl.gstatic.com/gb/js/scm_7385cc5883250b43a39405734c1bea59.js"}]);g.mcf("c",{});g.sg={c:""};if(l.a("1")){var wa=l.a("");I.push(["gc",{auto:wa,url:"//ssl.gstatic.com/gb/js/abc/gci_91f30755d6a6b787dcc2a4062e6e9824.js",libs:"googleapis.client:plusone:gapi.iframes"}]);var xa={version:"gci_91f30755d6a6b787dcc2a4062e6e9824.js",index:"",lang:"en"};H.gc=xa;var U=function(a){window.googleapis&&window.iframes?a&&a():(a&&O(a),N("gc"))};p("lGC",U);l.a("1")&&p("lPWF",U)};window.__PVT="";if(l.a("1")&&l.a("1")){var V=function(a){U(function(){K("pw",a);N("pw")})};p("lPW",V);I.push(["pw",{url:"//ssl.gstatic.com/gb/js/abc/pwm_45f73e4df07a0e388b0fa1f3d30e7280.js"}]);var W=[],ya=function(a){W[0]=a},za=function(a,b){var c=b||{};c._sn="pw";B(a,c)},Ba={signed:W,elog:za,base:"https://plusone.google.com/u/0",loadTime:(new Date).getTime()};H.pw=Ba;var X=function(a,b){for(var c=b.split("."),d=function(){var b=arguments;a(function(){for(var a=g,d=0,e=c.length-1;d<e;++d)a=a[c[d]];a[c[d]].apply(a,b)})},f=g,e=0,h=c.length-1;e<h;++e)f=
f[c[e]]=f[c[e]]||{};return f[c[e]]=d};X(V,"pw.clk");X(V,"pw.hvr");p("su",ya,g.pw)};function Ca(){function a(){for(var b;(b=e[h++])&&"m"!=b[0]&&!b[1].auto;);b&&(M(2,b[0]),b[1].url&&L(b[1].url,b[0]),b[1].libs&&m.d&&m.d(b[1].libs));h<e.length&&setTimeout(a,0)}function b(){0<f--?setTimeout(b,0):a()}var c=l.a("1"),d=l.a(""),f=3,e=I,h=0,k=window.gbarOnReady;if(k)try{k()}catch(r){da(r,"ml","or")}d?p("ldb",a):c?q(window,"load",b):b()}p("rdl",Ca);var Da={D:1,H:2,da:3,p:4,W:5,M:6,F:7,g:8,ha:9,U:10,L:11,T:12,S:13,N:14,Q:15,P:16,fa:17,w:18,O:19,ga:20,ea:21,u:22,G:23,ja:24,ka:25,ia:26,A:27,j:28,o:29,k:30,ca:31,Z:32,$:33,J:34,K:35,ba:36,aa:37,Y:38,B:39,R:40,v:41,X:42,V:43,h:48,C:49,I:500},Y=[1,2,3,4,5,6,9,10,11,13,14,28,29,30,34,35,37,38,39,40,41,42,43,48,49,500];var Z=l.b("0.001",1E-4),Ea=l.b("1",1),Fa=!1,Ga=!1;if(l.a("1")){var Ha=Math.random();Ha<=Z&&(Fa=!0);Ha<=Ea&&(Ga=!0)}var Ia=Da,$=null;function Ja(){var a=0,b=function(b,d){l.a(d)&&(a|=b)};b(1,"");b(2,"");b(4,"");b(8,"");return a}
function Ka(a,b){var c=Z,d=Fa,f;f=a;if(!$){$={};for(var e=0;e<Y.length;e++){var h=Y[e];$[h]=!0}}if(f=!!$[f])c=Ea,d=Ga;if(d){d=encodeURIComponent;g.rp?(f=g.rp(),f="-1"!=f?f:"1"):f="1";c=["//www.google.com/gen_204?atyp=i&zx=",(new Date).getTime(),"&oge=",a,"&ogex=",d("17483"),"&ogev=",d("_qTtU-ijN8iZogT8uoCYDw"),"&ogf=",g.bv.f,"&ogp=",d("22"),"&ogrp=",d(f),"&ogsr=",Math.round(1/c),"&ogv=",d("1407723702.0"),"&oggv="+
d("es_plusone_gc_20140723.0_p0"),"&ogd=",d("com"),"&ogl=",d("en"),"&ogc=",d("NZL"),"&ogus=",Ja()];if(b){"ogw"in b&&(c.push("&ogw="+b.ogw),delete b.ogw);var k;f=b;e=[];for(k in f)0!=e.length&&e.push(","),e.push(La(k)),e.push("."),e.push(La(f[k]));k=e.join("");""!=k&&(c.push("&ogad="),c.push(d(k)))}F(c.join(""))}}function La(a){"number"==typeof a&&(a+="");return"string"==typeof a?a.replace(".","%2E").replace(",","%2C"):a}C=Ka;p("il",C,G);var Ma={};H.il=Ma;setTimeout(function(){C(Ia.g)},0);}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{var b=window.gbar.i.i;var c=window.gbar;var f=function(d){try{var a=document.getElementById("gbom");a&&d.appendChild(a.cloneNode(!0))}catch(e){b(e,"omas","aomc")}};c.aomc=f;}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{var a=window.gbar;a.mcf("pm",{p:""});}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{window.gbar.rdl();}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
if (window['_OC_timingAction']) {window['_OC_timingAction']('patents_refpage');}</script><style>#gbar,#guser{font-size:13px;padding-top:1px !important;}#gbar{float:left;height:22px}#guser{padding-bottom:7px !important;text-align:right}.gbh,.gbd{border-top:1px solid #c9d7f1;font-size:1px}.gbh{height:0;position:absolute;top:24px;width:100%}#gbs,.gbm{background:#fff;left:0;position:absolute;text-align:left;visibility:hidden;z-index:1000}.gbm{border:1px solid;border-color:#c9d7f1 #36c #36c #a2bae7;z-index:1001}.gb1{margin-right:.5em}.gb1,.gb3{zoom:1}.gb2{display:block;padding:.2em .5em}.gb2,.gb3{text-decoration:none !important;border-bottom:none}a.gb1,a.gb4{text-decoration:underline !important}a.gb1,a.gb2,a.gb3,a.gb4{color:#00c !important}.gbi .gb3,.gbi .gb2,.gbi .gb4{color:#dd8e27 !important}.gbf .gb3,.gbf .gb2,.gbf .gb4{color:#900 !important}a.gb2:hover{background:#36c;color:#fff !important}#gbar .gbz0l{color:#000 !important;cursor:default;font-weight:bold;text-decoration:none !important}
#gbar { padding:.3em .6em !important;}</style></head><body  topmargin="3" marginheight="3"><div id=gbar><nobr><a onclick=gbar.qs(this);gbar.logger.il(1,{t:1}); class=gb1 id=gb_1 href="https://www.google.com/search?sa=N&tab=tw">Search</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:2}); class=gb1 id=gb_2 href="http://www.google.com/search?hl=en&tbm=isch&source=og&sa=N&tab=ti">Images</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:8}); class=gb1 id=gb_8 href="http://maps.google.com/maps?hl=en&sa=N&tab=tl">Maps</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:78}); class=gb1 id=gb_78 href="https://play.google.com/?hl=en&sa=N&tab=t8">Play</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:36}); class=gb1 id=gb_36 href="http://www.youtube.com/results?sa=N&tab=t1">YouTube</a> <a onclick=gbar.logger.il(1,{t:5}); class=gb1 id=gb_5 href="http://news.google.com/nwshp?hl=en&tab=tn">News</a> <a onclick=gbar.logger.il(1,{t:23}); class=gb1 id=gb_23 href="https://mail.google.com/mail/?tab=tm">Gmail</a> <a onclick=gbar.logger.il(1,{t:25}); class=gb1 id=gb_25 href="https://drive.google.com/?tab=to">Drive</a> <a class=gb3 href="http://www.google.com/intl/en/options/" onclick="this.blur();gbar.tg(event);return !1" aria-haspopup=true><u>More</u> <small>&#9660;</small></a><div class=gbm id=gbi><a onclick=gbar.logger.il(1,{t:24}); class=gb2 id=gb_24 href="https://www.google.com/calendar?tab=tc">Calendar</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:51}); class=gb2 id=gb_51 href="http://translate.google.com/?hl=en&sa=N&tab=tT">Translate</a><a onclick=gbar.logger.il(1,{t:17}); class=gb2 id=gb_17 href="http://www.google.com/mobile/?hl=en&tab=tD">Mobile</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:10}); class=gb2 id=gb_10 href="http://www.google.com/search?hl=en&tbo=u&tbm=bks&source=og&sa=N&tab=tp">Books</a><a onclick=gbar.logger.il(1,{t:212}); class=gb2 id=gb_212 href="https://wallet.google.com/manage/?tab=ta">Wallet</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:6}); class=gb2 id=gb_6 href="http://www.google.com/search?hl=en&tbo=u&tbm=shop&source=og&sa=N&tab=tf">Shopping</a><a onclick=gbar.logger.il(1,{t:30}); class=gb2 id=gb_30 href="http://www.blogger.com/?tab=tj">Blogger</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:27}); class=gb2 id=gb_27 href="http://www.google.com/finance?sa=N&tab=te">Finance</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:31}); class=gb2 id=gb_31 href="https://plus.google.com/photos?sa=N&tab=tq">Photos</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:12}); class=gb2 id=gb_12 href="http://www.google.com/search?hl=en&tbo=u&tbm=vid&source=og&sa=N&tab=tv">Videos</a><div class=gb2><div class=gbd></div></div><a onclick=gbar.logger.il(1,{t:66}); href="http://www.google.com/intl/en/options/" class=gb2>Even more &raquo;</a></div></nobr></div><div id=guser width=100%><nobr><span id=gbn class=gbi></span><span id=gbf class=gbf></span><span id=gbe></span><a target=_top id=gb_70 href="https://www.google.com/accounts/Login?service=&continue=http://www.google.com/patents%3Fhl%3Den&hl=en" class=gb4>Sign in</a><div style="display: none"><div class=gbm id=gbd5 aria-owner=gbg5><div class=gbmc><ol id=gbom class=gbmcc></ol></div></div></div></nobr></div><div class=gbh style=left:0></div><div class=gbh style=right:0></div><div role="alert" style="position: absolute; left: 0; right: 0;"><a href="http://www.google.com/patents/us5681946?hl=en&amp;output=html_text" title="Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader."><img border="0" src="http://www.google.com/images/cleardot.gif"alt="Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader."></a></div><div id="guser"><nobr></nobr></div><div style="clear:both;"></div><div id="gb-top-search-box" class="gb-top-search-box-small gb-reset"><table><tr><td class="logo"><a href="http://www.google.com/patents" class="logo-link"><img class="logo-img" src="/intl/en/images/logos/google_logo_41.png" alt="Go to Google Books Home" height="41"/></a></td><td><form action="http://www.google.com/search" name="f" id="vheadf" method="get"><span id="hf"></span><input type="hidden" name="tbm" value="pts"/><input type="hidden" name="tbo" value="1"/><input type="hidden" name="hl" value="en"/><table><tr><td><div class="inputs"><table><tr><td><div class="text-input"><input type="text" name="q" id="vheadq" class="text" maxlength="2048" size="31" value="" title="Search Patents" accesskey="s" autocomplete="off"/><script>window._OC_autoDir &&window._OC_autoDir('vheadq', 'tia-vheadq');</script></div></td><td><div class="submit-input"><input name="btnG" class="submit" type="submit" value=""/></div></td></tr></table></div></td><td class="col-ext-links"><div class="ext-links"><a href="http://www.google.com/advanced_patent_search">&lt;nobr&gt;Advanced Patent Search&lt;/nobr&gt;</a></div></td></tr></table></form></td></tr></table></div><div class="kd-appbar"><h2 class="kd-appname"><a href="/patents">Patents</a></h2><div class="kd-buttonbar left" id="left-toolbar-buttons"><a id="appbar-write-review-link" href=""></a><a id="appbar-view-print-sample-link" href=""></a><a id="appbar-view-ebook-sample-link" href=""></a><a id="appbar-patents-prior-art-finder-link" href="https://www.google.com/patents/related/US5681946"></a><a id="appbar-patents-discuss-this-link" href="http://www.google.com/url?id=DhZEBAABERAJ&amp;q=http://patents.stackexchange.com/redirect/google-patents%3Fpatent%3DUS5681946&amp;usg=AFQjCNHLPkuz6vrM-xnj8ps6dbABNFoeqw" data-is-grant="true"></a><a id="appbar-read-patent-link" href="//docs.google.com/viewer?url=patentimages.storage.googleapis.com/pdfs/US5681946.pdf"></a><a id="appbar-download-pdf-link" href="//patentimages.storage.googleapis.com/pdfs/US5681946.pdf"></a></div><div class="kd-buttonbar right" id="right-toolbar-buttons"></div></div><div id="books-microdata" itemscope=""itemtype="http://schema.org/Book"itemid="http://www.google.com/patents/US5681946" style="display:none"><span itemprop="description">A method of recovering a biopolymer from solution involves the use of magnetically attractable beads which do not specifically bind the polymer. The beads are suspended in the solution. Then the polymer is precipitated out of solution and becomes non-specifically associated with the beads. When the beads...</span><span itemprop="url">http://www.google.com/patents/US5681946?utm_source=gb-gplus-share</span><span class="main-title" itemprop="name">Patent US5681946 - Precipitating polymers</span><img itemprop="image" src="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"alt="Patent US5681946 - Precipitating polymers" title="Patent US5681946 - Precipitating polymers"></div><div style="display: none"><ol id="ofe-gear-menu-contents" class="gbmcc"><li class="gbe gbmtc"><a class="gbmt goog-menuitem-content" id="" href="http://www.google.com/advanced_patent_search">Advanced Patent Search</a></li></ol></div><table id="viewport_table" cellpadding="0" style="clear:both" cellspacing="0"><tr><td id="viewport_td"><div class=vertical_module_list_row><div id=intl_patents class=about_content><div id=intl_patents_v><table class="patent-bibdata"><tr><td class="patent-bibdata-heading">Publication number</td><td class="single-patent-bibdata">US5681946 A</td></tr><tr><td class="patent-bibdata-heading">Publication type</td><td class="single-patent-bibdata">Grant</td></tr><tr><td class="patent-bibdata-heading">Application number</td><td class="single-patent-bibdata">US 08/627,097</td></tr><tr><td class="patent-bibdata-heading">Publication date</td><td class="single-patent-bibdata">Oct 28, 1997</td></tr><tr><td class="patent-bibdata-heading">Filing date</td><td class="single-patent-bibdata">Apr 3, 1996</td></tr><tr><td class="patent-bibdata-heading">Priority date<span class="patent-tooltip-anchor patent-question-icon"data-tooltip-text="The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed."></span></td><td class="single-patent-bibdata">Feb 13, 1990</td></tr><tr><td class="patent-bibdata-heading">Fee status<span class="patent-tooltip-anchor patent-question-icon"data-tooltip-text="The fee status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status or dates listed."></span></td><td class="single-patent-bibdata">Paid</td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Also published as</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="/patents/US5523231">US5523231</a></span></span></td></tr><tr class="patent-bibdata-list-row alternate-patent-number"><td class="patent-bibdata-heading">Publication number</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value">08627097, </span><span class="patent-bibdata-value">627097, </span><span class="patent-bibdata-value">US 5681946 A, </span><span class="patent-bibdata-value">US 5681946A, </span><span class="patent-bibdata-value">US-A-5681946, </span><span class="patent-bibdata-value">US5681946 A, </span><span class="patent-bibdata-value">US5681946A</span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Inventors</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Michael+Alan+Reeve%22">Michael Alan Reeve</a></span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Original Assignee</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=inassignee:%22Amersham+International+Plc%22">Amersham International Plc</a></span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Export Citation</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="/patents/US5681946.bibtex">BiBTeX</a>, </span><span class="patent-bibdata-value"><a href="/patents/US5681946.enw">EndNote</a>, </span><span class="patent-bibdata-value"><a href="/patents/US5681946.ris">RefMan</a></span></span></td></tr><tr class="patent-internal-links"><td colspan=2><span class="patent-bibdata-value"><a href="#backward-citations">Patent Citations</a> (18),</span> <span class="patent-bibdata-value"><a href="#npl-citations">Non-Patent Citations</a> (8),</span> <span class="patent-bibdata-value"><a href="#forward-citations">Referenced by</a> (50),</span> <span class="patent-bibdata-value"><a href="#classifications">Classifications</a> (26),</span> <span class="patent-bibdata-value"><a href="#legal-events">Legal Events</a> (8)</span> </td></tr><tr><td colspan=2 class="patent-bibdata-external-link-spacer-top"></td></tr><tr class="patent-bibdata-external-link-spacer-bottom"></tr><tr><td colspan=2><span class="patent-bibdata-heading">External Links:&nbsp;</span><span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=DhZEBAABERAJ&q=http://patft.uspto.gov/netacgi/nph-Parser%3FSect2%3DPTO1%26Sect2%3DHITOFF%26p%3D1%26u%3D/netahtml/PTO/search-bool.html%26r%3D1%26f%3DG%26l%3D50%26d%3DPALL%26RefSrch%3Dyes%26Query%3DPN/5681946&usg=AFQjCNFhOO7sOcdAIMvLiqV5DluvSRkJPw">USPTO</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=DhZEBAABERAJ&q=http://assignments.uspto.gov/assignments/q%3Fdb%3Dpat%26pat%3D5681946&usg=AFQjCNHW43eXmlhfS1CaAii2E5i3Sqfg3w">USPTO Assignment</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=DhZEBAABERAJ&q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DUS%26NR%3D5681946A%26KC%3DA%26FT%3DD&usg=AFQjCNFVyrKVF0GZgkzSmlabUX3S0-8M4Q">Espacenet</a></span></span></td></tr><tr class="patent-bibdata-group-spacer"></tr></table><div class="number-and-title"><span class="patent-title"><invention-title mxw-id="PT54217530" lang="EN" load-source="patent-office">Precipitating polymers</invention-title></span><br><span class="patent-number">US 5681946 A</span></div><div class="patent-section patent-abstract-section"><div class="patent-section-header"><span class="patent-section-title">Abstract</span></div><div class="patent-text"><abstract mxw-id="PA37691120" lang="EN" load-source="patent-office"> <div class="abstract">A method of recovering a biopolymer from solution involves the use of magnetically attractable beads which do not specifically bind the polymer. The beads are suspended in the solution. Then the polymer is precipitated out of solution and becomes non-specifically associated with the beads. When the beads are magnetically drawn down, the polymer is drawn down with them. The polymer can subsequently be resolubilized and separated from the beads.</div>
  </abstract></div></div><div class="patent-section patent-drawings-section"><div class="patent-section-header"><span class="patent-section-title">Images<span class="patent-section-count">(4)</span></span></div><div class="patent-drawings-body"><div class="patent-drawings-carousel"><div class="drawings"><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5681946-1.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5681946-1.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5681946-2.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5681946-2.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5681946-3.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5681946-3.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5681946-4.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5681946-4.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div></div></div><div class="patent-drawings-control patent-drawings-prev"><img class="patent-drawings-button-img" alt="Previous page"src="/googlebooks/images/kennedy/page_left.png"width="21" height="21" /></div><div class="patent-drawings-control patent-drawings-next"><img class="patent-drawings-button-img" alt="Next page"src="/googlebooks/images/kennedy/page_right.png"width="21" height="21" /></div></div></div><div class="patent-post-drawings"></div><div class="patent-section patent-claims-section"><div class="patent-section-header"><span class="patent-section-title">Claims<span class="patent-section-count">(8)</span></span></div><div class="patent-text"><div mxw-id="PCLM5146628" lang="EN" load-source="patent-office" class="claims">
    <claim-statement>I claim:</claim-statement> <div class="claim"> <div num="1" class="claim">
      <div class="claim-text">1. A method of making a product solution containing a nucleic acid by treating a starting solution containing the nucleic acid by the use of suspended magnetically attractable beads which do not specifically bind the nucleic acid, comprising the steps of:<div class="claim-text">precipitating the nucleic acid out of the starting solution in the presence of the suspended magnetically attractable beads whereby a nucleic acid precipitate becomes non-specifically associated with the beads,</div> <div class="claim-text">applying a magnetic field to draw down the precipitate of the nucleic acid and the associated beads and to form a first supernatant liquid,</div> <div class="claim-text">separating the precipitate and the associated beads from the first supernatant liquid,</div> <div class="claim-text">adding a liquid to the precipitate and the associated beads to re-dissolve the nucleic acid and re-suspend the beads,</div> <div class="claim-text">applying a magnetic field to draw down the beads and to form a second supernatant liquid, and</div> <div class="claim-text">separating from the beads the second supernatant liquid as said product solution containing the nucleic acid.</div> </div>
    </div>
    </div> <div class="claim-dependent"> <div num="2" class="claim">
      <div class="claim-text">2. The method as claimed in claim 1, wherein all of the beads have been pre-treated with a phosphate solution to reduce the tendency of the beads to bind to a nucleic acid.</div>
    </div>
    </div> <div class="claim"> <div num="3" class="claim">
      <div class="claim-text">3. A method of making a product solution containing low molecular weight nucleic acid by treating a starting bacterial lysate containing low molecular weight nucleic acid by the use of suspended magnetically attractable beads which do not specifically bind the nucleic acid, comprising the steps of:<div class="claim-text">forming in the bacterial lysate a first precipitate selected from the group consisting of cell debris, protein and chromosomal DNA, in the presence of first suspended magnetically attractable beads, which first precipitate becomes non-specifically associated with the first beads,</div> <div class="claim-text">applying a magnetic field to draw down the first precipitate and the associated first beads and to form a supernatant starting solution containing the low molecular weight nucleic acid,</div> <div class="claim-text">recovering the starting solution containing the low molecular weight nucleic acid from the first precipitate and the associated first beads,</div> <div class="claim-text">precipitating the low molecular weight nucleic acid out of the starting solution in the presence of second suspended magnetically attractable beads whereby a low molecular weight nucleic acid precipitate becomes non-specifically associated with the second beads,</div> <div class="claim-text">applying a magnetic field to draw down the low molecular weight nucleic acid precipitate and the second associated beads and to form a first supernatant liquid,</div> <div class="claim-text">separating the low molecular weight nucleic acid precipitate and the associated second beads from the first supernatant liquid,</div> <div class="claim-text">adding a liquid to the low molecular weight nucleic acid precipitate to re-dissolve the nucleic acid and re-suspend the second beads,</div> <div class="claim-text">applying a magnetic field to draw down the second beads, and</div> <div class="claim-text">separating from the second beads a second supernatant liquid as said product solution containing the low molecular weight nucleic acid.</div> </div>
    </div>
    </div> <div class="claim-dependent"> <div num="4" class="claim">
      <div class="claim-text">4. The method as claimed in claim 3, wherein all of the beads have been pre-treated with a phosphate solution to reduce the tendency of the beads to bind to a nucleic acid.</div>
    </div>
    </div> <div class="claim"> <div num="5" class="claim">
      <div class="claim-text">5. A method of making a nucleic acid-containing liquid by treating a solution containing protein and nucleic acid by the use of magnetically attractable beads which do not specifically bind the nucleic acid, comprising the steps of:<div class="claim-text">forming in the solution a first precipitate comprising protein and nucleic acid in the presence of the suspended magnetically attractable beads which first precipitate becomes non-specifically associated with the beads,</div> <div class="claim-text">applying a magnetic field to draw down the first precipitate and associated beads and to form a first supernatant liquid, separating the first precipitate and associated beads from the first supernatant liquid,</div> <div class="claim-text">adding a first liquid to the first precipitate and associated beads to selectively re-dissolve the protein and re-suspend the beads associated with the nucleic acid,</div> <div class="claim-text">applying a magnetic field to draw down a second precipitate of the nucleic acid and the associated beads and to form a second supernatant liquid containing the protein,</div> <div class="claim-text">separating the second supernatant liquid containing the protein from the second precipitate and associated beads,</div> <div class="claim-text">adding a second liquid to the second precipitate to re-dissolve the nucleic acid and re-suspend the beads,</div> <div class="claim-text">applying a magnetic field to draw down the beads and to form a third supernatant liquid containing the nucleic acid, and</div> <div class="claim-text">separating from the beads the third supernatant nucleic acid-containing liquid.</div> </div>
    </div>
    </div> <div class="claim-dependent"> <div num="6" class="claim">
      <div class="claim-text">6. The method as claimed in claim 5, wherein all of the beads have been pre-treated with a phosphate solution to reduce the tendency of the beads to bind to a nucleic acid.</div>
    </div>
    </div> <div class="claim"> <div num="7" class="claim">
      <div class="claim-text">7. A method for recovering nucleic acid from a starting solution of bacteriophage, by the use of magnetically attractable beads which do not specifically bind said bacteriophage, which method comprises the steps:<div class="claim-text">precipitating said bacteriophage out of the starting solution in the presence of the first suspended magnetically attractable beads whereby the bacteriophage becomes non-specifically associated with the beads;</div> <div class="claim-text">applying a magnetic field to draw down the precipitate of the bacteriophage and the associated first beads and to form a first supernatant;</div> <div class="claim-text">separating the bacteriophage precipitate and the associated first beads from the first supernatant;</div> <div class="claim-text">re-suspending the bacteriophage precipitate and separating the associated first beads from the bacteriophage;</div> <div class="claim-text">lysing said bacteriophage to form a lysate solution comprising protein and nucleic acid;</div> <div class="claim-text">precipitating out of the lysate solution the nucleic acid in the presence of second suspended magnetically attractable beads whereby a nucleic acid precipitate becomes non-specifically associated with the second beads;</div> <div class="claim-text">applying a magnetic field to draw down the nucleic acid precipitate and the associated second beads and to form a second supernatant liquid containing the protein;</div> <div class="claim-text">separating the nucleic acid precipitate and associated second beads from the second supernatant liquid;</div> <div class="claim-text">adding a liquid to the nucleic acid precipitate to re-dissolve the nucleic acid and re-suspend the second beads;</div> <div class="claim-text">applying a magnetic field to draw down the second beads and to form a third supernatant liquid containing the nucleic acid; and</div> <div class="claim-text">separating the third supernatant liquid containing the nucleic acid from the associated second beads.</div> </div>
    </div>
    </div> <div class="claim-dependent"> <div num="8" class="claim">
      <div class="claim-text">8. The method as claimed in claim 7, wherein all of the beads have been pre-treated with a phosphate solution to reduce the tendency of the beads to bind to a nucleic acid.</div>
    </div>
  </div> </div></div></div><div class="patent-section patent-description-section"><div class="patent-section-header"><span class="patent-section-title">Description</span></div><div class="patent-text"><div mxw-id="PDES67035043" lang="EN" load-source="patent-office" class="description">
    <p>This is a divisional application of Ser. No. 08/253,212, filed Jun. 2, 1994, now U.S. Pat. No. 5,523,231, which is a continuation of now abandoned application Ser. No. 07/855,036, filed May 1, 1992, which is the U.S. national stage of PCT/GB91/00212, filed Feb. 13, 1991.</p>
    <heading>I. BACKGROUND OF THE INVENTION</heading> <p>Many techniques in Molecular Biology, Biochemistry and Chemistry rely upon the process of precipitation. There are two types of precipitation.</p>
    <p>In the first type of precipitation, the components from a complex solution that are not of interest are selectively precipitated. The precipitate and supernatant are then separated (usually by centrifugation or filtration) and the supernatant is kept for further use.</p>
    <p>In the second type of precipitation, the components of interest from a complex solution are selectively precipitated. The precipitate and supernatant are separated (again by centrifugation or filtration) and the precipitate is kept for further use. This precipitate may well be redissolved for further use.</p>
    <p>Examples of precipitation that are of particular relevance to this invention will now be discussed.</p>
    <p>a. Alcohol Precipitation of Nucleic Acid Molecules from Solution:</p>
    <p>Alcohol precipitation of nucleic acid molecules from solution is a standard procedure for the concentration and/or purification of these species from complex solutions. Typical methods involve the addition of salt (e.g. 0.1 volumes of 2.5M sodium acetate (pH 5.2)) to a solution containing nucleic acids followed by addition of an alcohol (e.g. 2.5 volumes of ethanol). The nucleic acids then precipitate. The precipitated nucleic acid molecules aggregate (usually with the aid of reduced temperatures; e.g. 5 minutes on dry ice) and are recovered by centrifugation. After removal of the supernatant, the pelleted precipitate is normally redissolved in the required volume of an appropriate buffer. The nucleic acid may be DNA (partially or wholly single or double stranded), RNA (partially or wholly single or double stranded), mixtures of any of the above or a hybrid RNA/DNA species. The salt used may be sodium acetate, sodium chloride, potassium acetate, potassium chloride, ammonium acetate, ammonium chloride, guanidinium thiocyanate, guanidinium isothiocyanate, guanidinium chloride or mixtures of the above. The alcohol used is normally ethanol or isopropanol.</p>
    <p>b. Precipitation of Bacteriophage and Other Viruses from Solution:</p>
    <p>Precipitation of bacteriophage and other viruses from solution by the addition of solutions containing high concentrations of highly hydratable polymers, such as polyethylene glycol (PEG), and salts, such as sodium chloride, is a standard procedure for the concentration and/or purification of these species from complex solutions. The bacteriophage or other viruses precipitated in this way may be used for nucleic acid extraction, protein extraction, infection of host cells, structural studies or immunological studies. A typical procedure involves the addition of 0.2 volumes of 20% (w/v) PEG in 2.5M sodium chloride to the complex solution known to contain the bacteriophage or other viruses. The bacteriophage or other viruses precipitate. The precipitated particles then aggregate (normally with the aid of incubation at reduced temperatures; e.g. 60 minutes at 4° C.) and are recovered by centrifugation. After removal of the supernatant, the pellet (comprising precipitated particles of bacteriophage or other viruses) is normally redissolved in the required volume of an appropriate buffer. The bacteriophage may be filamentous (e.g. M13) or complex (e.g. lambda). They may infect bacteria, animal or plant cells and they may be DNA-containing or RNA-containing.</p>
    <p>c. Removal of Bacterial DNA, Proteins and Membranes from Bacterial Lysates:</p>
    <p>Another type of precipitation of interest to Molecular Biologists is used for the removal of bacterial DNA, proteins and membranes from bacterial lysates containing, in addition to the above, RNA and plasmid DNA and/or cosmid DNA and/or bacteriophage DNA. This forms the basis of the alkaline lysis procedure for preparations of low molecular weight DNA. In this procedure, the bacterial cells (e.g. E. coli) are lysed by treatment with sodium hydroxide (e.g. 200 mM) and the detergent sodium dodecyl sulphate (SDS) (e.g. 0.3-1.0% (w/v)). Addition of a mixture of either sodium or potassium acetate at low pH (e.g. 0.5 times the volume of lysis buffer of 3M sodium or potassium acetate adjusted to pH 4.8 with acetic acid) leads to the formation of a precipitate containing protein, membrane fragments and the entrapped bacterial DNA. The RNA and low molecular weight DNA species are not entrapped in this precipitate and can be recovered from the supernatant after centrifugation or filtration of the precipitate. The low molecular weight DNA species can be purified and/or concentrated, along with cellular RNA, by subsequent alcohol precipitation from this supernatant as described above. The DNA species extracted by this procedure may be plasmid, cosmid or bacteriophage-derived. The volume of cells lysed can be as little as a few microliters or as large as many liters of bacterial culture.</p>
    <heading>II. SUMMARY OF THE INVENTION</heading> <p>In one aspect this invention provides a method of treating a solution of a polymer by the use of magnetically attractable beads which do not specifically bind the polymer, comprising the steps of:</p>
    <p>suspending the magnetically attractable beads in the solution,</p>
    <p>precipitating the polymer out of solution whereby it becomes non-specifically associated with the beads,</p>
    <p>applying a magnetic field to draw down a precipitate of the beads and the associated polymer, and</p>
    <p>separating the precipitate from a supernatant liquid.</p>
    <p>The key to the invention is the use of magnetically attractable beads (hereinafter magnetic beads). The nature of the magnetic beads is not critical, and commercially available beads may be used. The beads typically have an average diameter in the range 1 to 100 μm, and comprise finely divided magnetizable material encapsulated in organic polymer.</p>
    <p>Or the organic polymer may be omitted. Beads of magnetic iron oxide are commercially available. Such beads have been successfully used in this invention in sizes ranging from below 1 μm up to 40 μm. Even the larger beads remain in suspension at least for the duration of the precipitation step; their subsequent tendency to settle out assists the magnetic field in drawing down the precipitate.</p>
    <p>To improve recovery of precipitated polymers, the beads may be pretreated to reduce any unwanted tendency to bind the polymers permanently. For example, when the polymers are nucleic acids, the beads may be pre-treated with a phosphate solution. This treatment is believed to phosphatize any exposed magnetisable material, and may not be necessary if the magnetisable material is completely encapsulated in inert polymer.</p>
    <p>The beads are preferably added to the solution either before, or together with, a reagent used to precipitate the polymer. Alternatively, the beads may be added after the precipitation step, under conditions to cause the pre-existing precipitate to become associated with them.</p>
    <p>The starting solution is preferably aqueous. However starting solutions in polar or non-polar organic solvents are envisaged, particularly when the polymer is of synthetic origin.</p>
    <p>While the invention is applicable to polymers generally, it is of particular importance in relation to biopolymers. Biopolymers are polymers found in biological systems. The nature of the biopolymer is not critical to the invention. Biopolymers include nucleic acids (DNA and RNA), proteins, polypeptides, polysaccharides, cell membrane material, bacteriophages, virus, and procaryotic and eucaryotic cells.</p>
    <p>At the outset, the polymer or biopolymer is present in solution, the term solution being used broadly to cover permanently stable suspensions in which the polymer molecules are not aggregated.</p>
    <p>It is a feature of the invention that the magnetic beads do not specifically bind the polymer. By this feature, the present invention is distinguished from many prior techniques which involve providing a coating on the surface of magnetic beads designed to specifically bind the substance to be drawn down out of solution. When the polymer is precipitated out of solution in the presence of the suspended magnetic beads, it becomes non-specifically associated with the beads. When the beads are drawn down by an applied magnetic field, the associated precipitated polymer is drawn down with them. But when in solution, the polymer does not become associated with the beads.</p>
    <p>When the solute is of more interest than the solvent, the method may be used either to concentrate an initially dilute solution, or to recover one or more polymers from a mixture of polymers, or for both these purposes in sequence. For a sequence of manipulations, the same beads can conveniently be used. The nature of the liquids used to dissolve or re-dissolve the polymer, and of reagents used to precipitate polymer, are not material to this invention. A skilled reader will have no difficulty in choosing liquids and reagents appropriate to his needs.</p>
    <p>In another aspect, the invention provides an automated device for performing this method, which device comprises an automated pipertot and a magnet which may be a permanent magnet or an electromagnet.</p>
    <heading>III. BRIEF DESCRIPTION OF THE DRAWINGS</heading> <p>FIG. 1a shows an example of magnetic bead induced separation of nucleic acids with alcohol precipitation in accordance with the present invention.</p>
    <p>FIG. 1b shows an example of magnetic bead induced precipitate separation of nucleic acids with phenol extraction in accordance with the present invention.</p>
    <p>FIG. 2 shows an example of magnetic bead precipitate separation of phage and viruses in accordance with the present invention.</p>
    <p>FIG. 3 shows an example of magnetic bead precipitate separation of low molecular weight DNA and RNA in accordance with the present invention.</p>
    <heading>IV. DETAILED DESCRIPTION OF THE INVENTION</heading> <p>The invention will now be discussed with reference to the three types of precipitation given in the introduction.</p>
    <p>a. Alcohol Precipitation of Nucleic Acid Molecules from Solution:</p>
    <p>Magnetic bead induced precipitate separation can be used to greatly improve the process of alcohol precipitation of nucleic acids. The alcohol precipitation procedure as modified by this invention is shown in FIG. 1a. Magnetic beads are added to the nucleic acid in solution. Salt is then added (the magnetic beads can also be added at the same time as the salt). The nucleic acid is still soluble at this stage. Alcohol is then added. This causes the nucleic acid to come out of solution. The precipitated nucleic acid aggregates around the suspended magnetic beads (which may well act as nucleation sites for this aggregation process). The aggregation stage may be assisted for some types of precipitations by chilling (though chilling does not appear to be necessary for simple precautions of plasmid, phage DNA, RNA and genomic DNA by this method). A magnetic field is then applied to the precipitation. This magnetic field is used to draw the complex of magnetic beads and precipitated nucleic acid to the bottom (or side) of the tube. The supernatant is then removed from the tube. At this point, the precipitate can be washed with ethanol, and/or isopropanol and/or 70% (v/v) ethanol to remove any residual salt, nucleotides, chemicals or organic solvents remaining from treatments of the nucleic acid prior to the precipitation step. The nucleic acid is insoluble in isopropanol, ethanol and 70% (v/v) ethanol. The nucleic acid therefore remains aggregated around the magnetic beads during washing. The washing step can thus be performed vigorously (e.g. by vortex mixing) without risk of losing the precipitate. After the washing step, if performed, the precipitate is redissolved in the required volume of an appropriate buffer in the absence of the magnetic field. Reapplication of the magnetic field to the tube results in just the magnetic beads being drawn to the bottom (or side) of the tube (as the nucleic acid is now dissolved rather than a precipitate as before). The redissolved nucleic acid can now be separated from the magnetic beads by collecting the supernatant containing the dissolved nucleic acid with a pipette whilst the beads are held against the bottom (or side) of the tube by the magnetic field.</p>
    <p>The modification of alcohol precipitation by this invention has several clear advantages over the conventional method of precipitation using centrifugation. The procedure, as modified by this invention, is:</p>
    <p>1. Faster (the modified procedure takes only 1-2 minutes, as opposed to 10-30 minutes for the conventional procedure using centrifugation).</p>
    <p>2. Not reliant upon centrifugation equipment.</p>
    <p>3. Readily suited to automation (a great many tubes could be placed over a large electromagnet and these could all be alcohol precipitated simultaneously using a multi channel pipetting device).</p>
    <p>4. Especially effective if the precipitate of nucleic acid is to be washed with isopropanol, ethanol or 70% ethanol (e.g. to remove any residual salt, nucleotides or organic solvents such as phenol). Washing can be performed rapidly with no risk of loss of material as can occur with the conventional method based upon centrifugation (where the pellet often detaches from the bottom of the tube during such washing).</p>
    <p>Magnetic bead induced precipitate separation can also be used to greatly improve the process of deproteinization and alcohol precipitation of nucleic acids. The deproteinization and alcohol precipitation procedure as modified by this invention is shown in FIG. 1b. DNA is given as the example in FIG. 4b, though the process is equally applicable to any type of nucleic acid. Magnetic beads are added to the protein and nucleic acid in solution. Salt is then added (the magnetic beads can also be added at the same time as the salt). The protein and nucleic acid are still soluble at this stage. Alcohol is then added. This causes the protein and nucleic acid to come out of solution. The precipitated protein and nucleic acid aggregate around the suspended magnetic beads (which may well act as nucleation sites for this aggregation process). The aggregation stage may be assisted for some types of precipitations by chilling (though chilling does not appear to be necessary for simple precipitations of plasmid, phage DNA, RNA and genomic DNA with protein extraction by this method). A magnetic field is then applied to the precipitation. This magnetic field is used to draw the complex of magnetic beads and precipitated protein and nucleic acid to the bottom (or side) of the tube. The supernatant is then removed from the tube. The protein and nucleic acid remain aggregated around the magnetic beads. Phenol and/or phenol/chloroform and/or phenol/ethanol is then added and the magnetic beads resuspended in the absence of the magnetic field. This resuspension extracts the precipitated protein from the magnetic beads whilst the nucleic acid remains still attached. A magnetic field is again applied to the tube. This magnetic field is used to draw the complex of precipitated nucleic acid and magnetic beads to the bottom (or side) of the tube. The phenolic supernatant (containing the extracted protein) is then removed from the tube. At this point, the precipitate can be washed with ethanol, and/or isopropanol and/or 70% (v/v) ethanol to remove any residual salt, nucleotides, chemicals or organic solvents remaining. The nucleic acid is insoluble in isopropanol, ethanol and 70% (v/v) ethanol. The nucleic acid therefore remains aggregated around the magnetic beads during washing. The washing step can thus be performed vigorously (e.g. by vortex mixing) without risk of losing the precipitate. After the washing step, if performed, the precipitate is redissolved in the required volume of an appropriate buffer in the absence of the magnetic field. Reapplication of the magnetic field to the tube results in just the magnetic beads being drawn to the bottom (or side) of the tube (as the nucleic acid is now dissolved rather than a precipitate as before). The redissolved nucleic acid can now be separated from the magnetic beads by collecting the supernatant containing the dissolved nucleic acid with a pipette whilst the beads are held against the bottom (or side) of the tube by the magnetic field.</p>
    <p>The modification of deproteinization and alcohol precipitation by this invention has several clear advantages over the conventional method of using centrifugation. The procedure, as modified by this invention, is:</p>
    <p>1. Faster (the modified procedure takes only 5-10 minutes, as opposed to 20-40 minutes for the conventional procedure using centrifugation).</p>
    <p>2. Not reliant upon centrifugation equipment.</p>
    <p>3. Readily suited to automation (a great many tubes could be placed over a large electromagnet and these could all be deproteinized and alcohol precipitated simultaneously using a multi channel pipetting device).</p>
    <p>4. Especially effective if the precipitate of nucleic acid is to be washed with isopropanol, ethanol or 70% ethanol (e.g. to remove any residual salt, nucleotides or organic solvents such as phenol). Washing can be performed rapidly with no risk of loss of material as can occur with the conventional method based upon centrifugation (where the pellet often detaches from the bottom of the tube during such washing).</p>
    <p>b. Precipitation of Bacteriophage and Other Viruses from Solution:</p>
    <p>Magnetic bead induced precipitate separation can be used to greatly improve the process of hydrateable polymer/salt precipitation of bacteriophage and other viruses. The hydrateable polymer/salt precipitation procedure as modified by this invention is shown in FIG. 2. Magnetic beads, hydrateable polymer (e.g. PEG) and salt (e.g. sodium chloride) are added to the bacteriophage or other vital particles in solution. This causes the particles of bacteriophage or other viruses to come out of solution. The precipitated particles aggregate round the suspended magnetic beads (which may well act as nucleation sites for this aggregation process). The aggregation stage may be assisted for some types of precipitations by chilling (though chilling does not appear to be necessary for simple precipitations of bacteriophage). A magnetic field is then applied to the precipitation. This magnetic field is used to draw the complex of magnetic beads and precipitated particles to the bottom (or side) of the tube. The supernatant is then removed from the tube. The precipitate is redissolved in the required volume of an appropriate buffer in the absence of the magnetic field. Reapplication of the magnetic field to the tube results in just the magnetic beads being drawn to the bottom (or side) of the tube (as the particles of bacteriophage or other viruses are now dissolved rather than a precipitate is before). The redissolved particles of bacteriophage or other viruses can not be separated from the magnetic beads by collecting the supernatant containing the dissolved particles with a pipette whilst the beads are held against the bottom (or side) of the tube by the magnetic field.</p>
    <p>The modification of hydrateable polymer/salt precipitation by this invention has several clear advantages over the conventional method of precipitation using centrifugation. The procedure, as modified by this invention, is:</p>
    <p>1. Faster (the modified procedure takes only 1-2 minutes, as opposed to 65-75 minutes for the conventional procedure using centrifugation).</p>
    <p>2. Not reliant upon centrifugation equipment.</p>
    <p>3. Readily suited to automation (a great many tubes could be placed over a large electromagnet and these could all be hydrateable polymer/salt precipitated simultaneously using a multi channel pipetting device).</p>
    <p>4. Less likely to produce aerosols of bacteriophage and other viruses than the conventional procedure based upon centrifugation. This is safer if the bacteriophage or other viruses are harmful and will result in less airborne microbial contamination in the laboratory.</p>
    <p>c. Removal of Bacterial DNA, Proteins and Membranes from Bacterial Lysates:</p>
    <p>Magnetic bead induced precipitate separation can also be used to greatly improve the precipitation of bacterial DNA, membranes and proteins from bacterial lysates containing RNA and low molecular weight DNA species. The preparation of RNA and low molecular weight DNA species as modified by this invention is shown in FIG. 3. Bacteria (containing the low molecular weight DNA species of interest) are lysed with a mixture of sodium hydroxide and SDS. This releases bacterial DNA, proteins, membranes, RNA and low molecular weight DNA into solution. Magnetic beads and either sodium or potassium acetate are then added at low pH. This causes the SDS, proteins and membranes to precipitate. The precipitate also entraps the bacterial DNA and the magnetic beads. A magnetic field is then applied to the precipitation. This magnetic field is used to draw the complex of magnetic beads and precipitated material to the bottom (or side) of the tube. The supernatant is then removed from the tube with a pipette whilst the complex of beads and precipitated material is held against the bottom (or side) of the tube by the magnetic field. The low molecular weight DNA can be purified and/or concentrated from this supernatant (along with any remaining cellular RNA that will also be purified) by alcohol precipitation as described above.</p>
    <p>The modification of low molecular weight DNA preparation by this invention has several clear advantages over the conventional method of precipitation using centrifugation. The procedure, as modified by this invention, is:</p>
    <p>1. Faster (the modified procedure takes only 5-10 minutes, as opposed to 30-60 minutes for the conventional procedure using centrifugation).</p>
    <p>2. Not reliant upon centrifugation equipment.</p>
    <p>3. Readily suited to automation (a great many tubes could be placed over a large electromagnet and these could all be precipitated simultaneously using a multi channel pipetting device).</p>
    <p>d. DNA Preparation from Bacteriophage or Other Viruses:</p>
    <p>Magnetic bead induced precipitate separation has been shown to greatly improve the process of hydrateable polymer/salt precipitation of bacteriophage and other viruses. The hydrateable polymer/salt precipitation has been shown in FIG. 2. Magnetic bead induced precipitate separation has also been shown to greatly improve the precipitation of bacterial DNA, membranes and proteins from bacterial lysates containing RNA and low molecular weight DNA species. The preparation of RNA and low molecular weight DNA species as modified by this invention has been shown in FIG. 3. The combination of these two procedures can be used to derive a novel procedure for the purification of low molecular weight DNA from bacteriophage or other viral particles. In this novel procedure, particles of bacteriophage or other viruses are precipitated using the magnetic bead method given in FIG. 3. The purified particles are then subjected to lysis by sodium hydroxide and SDS. This step separates the coat proteins from the DNA, with both being released into solution. Magnetic beads and either sodium or potassium acetate are then added at low pH. This causes the SDS and coat proteins to precipitate. The precipitate also entraps the magnetic beads. A magnetic field is then applied to the precipitation. This magnetic field is used to draw the complex of magnetic beads and precipitated material to the bottom (or side) of the tube. The supernatant is then removed from the tube with a pipette whilst the complex of beads and precipitated material is held against the bottom (or side) of the tube by the magnetic field. The low molecular weight DNA can be purified and/or concentrated from this supernatant by alcohol precipitation as described above. The modification of low molecular weight DNA preparation from bacteriophage or other viruses by this invention has several clear advantages over the conventional method of precipitation using centrifugation and other methods. The procedure, as modified by this invention, is:</p>
    <p>1. Faster (the modified procedure takes only 5-10 minutes, as opposed to 2-3 hours for the conventional procedure using centrifugation).</p>
    <p>2. Not reliant upon centrifugation equipment.</p>
    <p>3. Readily suited to automation (a great many tubes could be placed over a large electromagnet and these could all be precipitated simultaneously using a multi channel pipetting device).</p>
    <p>4. Not reliant upon organic solvent extraction (e.g. by phenol).</p>
    <p>5. Less likely to produce aerosols of bacteriophage and other viruses than the conventional procedure based upon centrifugation. This is safer if the bacteriophage or other viruses are harmful and will result in less airborne microbial contamination in the laboratory.</p>
    <p>6. Especially effective if the precipitate of nucleic acid is to be washed with isopropanol, ethanol or 70% ethanol. Washing can be performed rapidly with no risk of loss of material as can occur with the conventional method based upon centrifugation (where the pellet often detaches from the bottom of the tube during such washing).</p>
    <p>e. Precipitation of Bacteria from Solution</p>
    <p>Magnetic bead induced precipitate separation can also be used to effect a novel process of alcohol precipitation of cells e.g. bacterial cells. Magnetic beads are added to the bacteria in solution. Salt is then added (the magnetic beads can also be added at the same time as the salt). The bacteria are still soluble at this stage. Alcohol is then added. This causes the bacteria to come out of solution. The precipitated bacteria aggregate around the suspended magnetic beads (which may well act as nucleation sites for this aggregation process). A magnetic field is then applied to the precipitation. This magnetic field is used to draw the complex of magnetic beads and precipitated bacteria to the bottom (or side) of the tube. The supernatant is then removed from the tube. The precipitate is dissolved in the required volume of an appropriate buffer in the absence of the magnetic field. Reapplication of the magnetic field to the tube results in just the magnetic beads being drawn to the bottom (or side) of the tube (as the bacteria are now dissolved rather than a precipitate as before). The redissolved bacteria can now be separated from the magnetic beads by collecting the supernatant containing the dissolved bacteria with a pipette whilst the beads are held against the bottom (or side) of the tube by the magnetic field.</p>
    <p>Alternatively the bacteria can be lysed directly on the beads as described in IIIc for DNA preparation. The procedure as effected by this invention is:</p>
    <p>1. Faster (the modified procedure takes only 1-2 minutes, as opposed to 5-15 minutes for the conventional procedure using centrifugation).</p>
    <p>2. Not reliant upon centrifugation equipment.</p>
    <p>3. Readily suited for automation (a great many culture tubes could be placed over a large electromagnet and these could all be alcohol precipitated simultaneously using a multi channel pipetting device).</p>
    <heading>V. Reduction of the Invention to Practice</heading> <p>The magnetic beads used were cellulose/ferric oxide (50/50), with a particle size of 1-10 microns diameter. Beads were pretreated by soaking in 100 mM tetrasodium pyrophosphate solution, and stored at 4 degrees in 0.1% (w/v) sodium azide at a concentration of 50 mg/ml.</p>
    <p>a. An Example of Alcohol Precipitation of Nucleic Acid Using Magnetic Bead Induced Precipitate Separation:</p>
    <heading>EXAMPLE 1</heading> <p>Precipitations of plasmid (e.g. pBR322) can be performed according to the following protocol: Take pBR322 DNA in, for example, 100 μl of TE buffer (10 mM Tris-HCl (pH 8.0), 1 mM EDTA (pH 8.0)); add 1/10th volume (i.e. 10 μl) of a solution containing magnetic beads at 50 mg/ml and tRNA at 1 mg/ml (as carrier, this may be omitted if the concentration of nucleic acid is greater than about 10-25 μg/ml) in 2.5M sodium acetate adjusted to pH 5.2 with acetic acid; mix; add 2.5 volumes (i.e. 250 μl) of ethanol; mix; place over a permanent magnet to bring down the precipitate; remove the supernatant; wash the pellet in, for example, 100 μl of 70% (v/v) ethanol by resuspending with a pipette in the absence of the magnetic field, finally removing the supernatant (wash solution) with a pipette in the presence of the magnetic field; redissolve the pellet in the required volume of TE buffer.</p>
    <p>No loss occurs on omission of the chilling step for pBR322 DNA. Also, no loss occurs from washing the precipitate with 70% (v/v) ethanol for pBR322 DNA. The above procedure works equally well for human genomic DNA and for RNA.</p>
    <heading>EXAMPLE 2</heading> <p>Precipitation of pBR322 plasmid DNA with deproteinization can be performed according to the following protocol: Take, for example, pBR322 DNA in 20 μl of TE buffer (10 mM Tris-HCl (pH 8.0), 1 mM EDTA (pH 8.0)) containing protein (e.g. a 1/4 dilution of Rainbow Markers™ (Amersham International)); add 1/10th volume (i.e. 2 μl) of a solution containing magnetic beads at 50 mg/ml and tRNA at 1 mg/ml (as carrier, this may be omitted if the concentration of nucleic acid is greater than about 10-25 μg/ml) in 2.5M sodium acetate adjusted to pH 5.2 with acetic acid; mix; add 2.5 volumes (i.e. 50 μl) of ethanol; mix; place over a permanent magnet to bring down the precipitate; remove the supernatant; wash the pellet in, for example, 50 μl of phenol (or greater than 60% (v/v) phenol in ethanol) by resuspending with a pipette in the absence of the magnetic field, finally removing the supernatant (wash solution) with a pipette in the presence of the magnetic field; redissolve the pellet in the required volume of TE buffer. The yield of DNA falls off with less than 40% (v/v) phenol in ethanol used for protein extraction. No losses are incurred with this additional step of protein extraction compared to a protein-free ethanol precipitation. Ethanol precipitation from a solution heavily contaminated with protein is also seen to be dependent upon the extraction of the contaminating protein by a phenol containing solution (i.e. the DNA cannot be redissolved from the beads if protein extraction has not been performed). The successful extraction of the protein into the phenolic layer by this procedure can clearly be seen when using coloured proteins. The above procedure works equally well for human genomic DNA and for RNA.</p>
    <p>b. An Example of Hydrateable Polymer/Salt Precipitation of Bacteriophage Using Magnetic Bead Induced Precipitate Separation:</p>
    <heading>EXAMPLE 3</heading> <p>Precipitations can be performed on, for example, 1 ml samples of M13mp8 bacteriophage in 2xTY broth (precleared of bacteria by centrifugation) according to the following protocol: Add 0.4 volumes (i.e. 400 μl) of 2 mg/ml magnetic beads in 20% (w/v) PEG, 2.5M NaCl; mix; bring down magnetic beads and precipitate using a permanent magnet; redissolve magnetic bead pellet in the required volume of TE buffer.</p>
    <p>At 0.4 volumes, the amount of bacteriophage not brought down by the beads is negligible.</p>
    <heading>EXAMPLE 4</heading> <p>DNA preparations can be performed on, for example, 1 ml samples of M13mp8 bacteriophage in 2xTY broth (precleared of bacteria by centrifugation) according to the following protocol: Add 0.4 volumes (i.e. 400 μl) of 2 mg/ml magnetic beads in 20% (w/v) PEG, 2.5M NaCl; mix; bring down magnetic beads and precipitate using a permanent magnet; redissolve magnetic bead pellet in 1/5th volume (i.e. 200 μl) of TE buffer; extract with an equal volume (i.e. 200 μl) of phenol; remove aqueous (top) layer; add 1/10th volume (i.e. 20 μl) of a solution containing magnetic beads at 50 mg/ml and tRNA at 1 mg/ml (as carrier, this may be omitted if the concentration of nucleic acid is greater than about 10-25 μg/ml) in 2.5M sodium acetate adjusted to pH 5.2 with acetic acid; mix; add 2.5 volumes (i.e. 500 μl) of ethanol; mix; place over a permanent magnet to bring down the precipitate; remove the supernatant; wash the pellet in, for example, 100 μl of 70% (v/v) ethanol by resuspending with a pipette in the absence of the magnetic field, finally removing the supernatant (wash solution) with a pipette in the presence of the magnetic field; redissolve DNA in the required volume of TE buffer.</p>
    <heading>EXAMPLE 5</heading> <p>DNA preparations can also be performed on, for example, 1 ml samples of M13mp8 bacteriophage in 2xTY broth (precleared of bacteria by centrifugation) according to the following protocol: Add 0.4 volumes (i.e. 400 μl) of 2 mg/ml magnetic beads in 20% (w/v) PEG, 2.5M NaCl; mix; bring down magnetic beads and precipitate using a permanent magnet; redissolve magnetic bead pellet in 1/10th original volume (i.e. 100 μl) of 4M sodium perchlorate in TE buffer; now add 2.5 volumes (i.e. 250 μl) of ethanol; mix; place over a permanent magnet to bring down the precipitate; remove the supernatant; wash the pellet twice in, for example, 100 μl of 70% (v/v) ethanol by resuspending with a pipette in the absence of the magnetic field, finally removing the supernatant (wash solution) with a pipette in the presence of the magnetic field; redissolve DNA in the required volume of TE buffer.</p>
    <p>c. An Example of the Removal of Bacterial DNA, Proteins and Membranes from Bacterial Lysates Using Magnetic Bead Induced Precipitate Separation:</p>
    <heading>EXAMPLE 6</heading> <p>pUC19 DNA can be extracted from E. coli MC1061 cells by the following protocol: Take, for example, 250 μl of bacterial culture; add 1/5th volume (i.e. 50 μl) of 1.2M NaOH, 1.2% (w/v) SDS; mix; incubate 2 minutes at room temperature; now add 3/5th volume (i.e. 150 μl) of 10 mg/ml magnetic beads in 3M potassium acetate adjusted to pH 4.8 with acetic acid; mix; bring down precipitated material with a permanent magnet and keep supernatant; isopropanol precipitate the supernatant as follows: add 1/10th supernatant volume (i.e. 45 μl) of a solution containing magnetic beads at 50 mg/ml and tRNA at 1 mg/ml (as carrier, this may be omitted if the concentration of nucleic acid is greater than about 10-25 μg/ml) in 2.5M sodium acetate adjusted to pH 5.2 with acetic acid; mix; add 0.6 supernatant volumes (i.e. 270 μl) of isopropanol; mix; place over a permanent magnet to bring down the precipitate; remove the supernatant; wash the pellet in, for example, 100 μl of 70% (v/v) ethanol by resuspending with a pipette in the absence of the magnetic field, finally removing the supernatant (wash solution) with a pipette in the presence of the magnetic field; redissolve DNA in the required volume of TE buffer. Preparations can be incubated with 10 μg/ml ribonuclease A for 10 minutes at 37° C. before analysis.</p>
    <heading>EXAMPLE 7</heading> <p>pUC19 DNA can also be extracted from E. coli MC1061 cells by the following protocol: Take, for example, 500 μl of bacterial culture; add 1 volume (i.e. 500 μl) of a solution containing magnetic beads at 5 mg/ml in 0.2M sodium acetate (adjusted to pH 5.2 with acetic acid) dissolved in ethanol; mix; bring down precipitated bacteria with a permanent magnet; remove supernatant and discard; redissolve bacterial pellet in, for example, 300 μl of 0.2M NaOH, 0.2% (w/v) SDS; mix; incubate 2 minutes at room temperature; now add 1/2 volume (i.e. 150 μl) of 3M potassium acetate adjusted to pH 4.8 with acetic acid; mix; bring down precipitated material with a permanent magnet and keep supernatant; isopropanol precipitate the supernatant as follows: add 1/10th supernatant volume (i.e. 45 μl) of a solution containing magnetic beads at 50 mg/ml and tRNA at 1 mg/ml (as carrier, this may be omitted if the concentration of nucleic acid is greater than about 10-25 μg/ml) in 2.5M sodium acetate adjusted to pH 5.2 with acetic acid; mix; add 0.6 supernatant volumes (i.e. 270 μl) of isopropanol; mix; place over a permanent magnet to bring down the precipitate; remove the supernatant; wash the pellet in, for example, 100 μl of 70% (v/v) ethanol by resuspending with a pipette in the absence of the magnetic field, finally removing the supernatant (wash solution) with a pipette in the presence of the magnetic field; redissolve DNA in the required volume of TE buffer. Preparations can be incubated with 10 μg/ml ribonuclease A for 10 minutes at 37° C. before analysis.</p>
    <p>d. An Example of DNA Extraction from Bacteriophage Using Magnetic Bead Induced Precipitate Separation for: Hydrateable Polymer/Salt Precipitation, Removal of Coat Proteins and Alcohol Precipitation of the DNA:</p>
    <heading>EXAMPLE 8</heading> <p>M13mp8 phage can be precipitated with magnetic beads, PEG and NaCl as described in IIIb. DNA can then be prepared by the alkaline lysis procedure as described in IIIc (dissolving the PEG/NaCl/magnetic beads precipitate of bacteriophage particles in, for example, 250 μl of TE buffer for alkaline lysis). The alkaline lysis method gives M13mp8 DNA at about half the yield of the phenol extraction preparation.</p>
    <heading>VI. Other Types of Precipitation</heading> <p>These include the following:</p>
    <p>Precipitations of bacteria, tissue culture cells and blood cells by suitable precipitants (e.g. an equal volume of ethanolic 0.2M sodium acetate adjusted to pH 5.2 with acetic acid for E. coli) and magnetic bead induced precipitate separation.</p>
    <p>Ammonium sulphate precipitation of proteins with magnetic bead induced precipitate separation.</p>
    <p>Precipitation of proteins by salts other than ammonium sulphate and magnetic bead induced precipitate separation (e.g. sodium perchlorate, sodium iodide, guanidinium chloride, guanidinium thiocyanate, guanidinium isothiocyanate and other chaotropic agents).</p>
    <p>Precipitation of proteins by denaturants and magnetic bead induced precipitate separation.</p>
    <p>Precipitation of proteins by detergents and magnetic bead induced precipitate separation.</p>
    <p>Precipitation of nucleic acids by the detergent cetyl trimethyl ammonium bromide and magnetic bead induced precipitate separation.</p>
    <p>Precipitation or proteins and/or nucleic acids with agents such as trichloroacetic acid (that denature due to extremes of pH) and magnetic bead induced precipitate separation.</p>
    <p>Selective RNA precipitations from lithium chloride and magnetic bead induced precipitate separation.</p>
    <p>Selective precipitations of nucleic acids from other nucleic acids (e.g. precipitations of high molecular weight DNA from oligodeoxyribonucleotides and/or deoxynucleotide polyphosphates) which may work better using magnetic bead induced precipitate separation than centrifugation.</p>
    <p>Immune precipitations and magnetic bead induced precipitate separation.</p>
    <p>Complement fixation precipitations and magnetic bead induced precipitate separation.</p>
    <p>Blood clotting precipitations and magnetic bead induced precipitate separation.</p>
    <p>Latex bead precipitation assays and magnetic bead induced precipitate separation.</p>
    <p>Haemagluttination assays and magnetic bead induced precipitate separation.</p>
    </div></div></div><div class="patent-section patent-tabular-section"><a id="backward-citations"></a><div class="patent-section-header"><span class="patent-section-title">Patent Citations</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Cited Patent</th><th class="patent-data-table-th">Filing date</th><th class="patent-data-table-th">Publication date</th><th class="patent-data-table-th">Applicant</th><th class="patent-data-table-th">Title</th></tr></thead><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US3470057">US3470057</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jul 15, 1966</td><td class="patent-data-table-td patent-date-value">Sep 30, 1969</td><td class="patent-data-table-td ">Stuart Steel Protection Corp</td><td class="patent-data-table-td ">Pipe wrapping machine</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4001197">US4001197</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jun 12, 1975</td><td class="patent-data-table-td patent-date-value">Jan 4, 1977</td><td class="patent-data-table-td ">Sala Magnetics, Inc.</td><td class="patent-data-table-td ">Recovering single cell proteins from organisms</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4672040">US4672040</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jun 28, 1985</td><td class="patent-data-table-td patent-date-value">Jun 9, 1987</td><td class="patent-data-table-td ">Advanced Magnetics, Inc.</td><td class="patent-data-table-td ">Coated with a polysiloxane and coupled to a nucleic acid</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4710472">US4710472</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Sep 25, 1985</td><td class="patent-data-table-td patent-date-value">Dec 1, 1987</td><td class="patent-data-table-td ">The United States Of America As Represented By The Secretary Of The Navy</td><td class="patent-data-table-td ">Removing magnetic bead-coated cells from a system</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5091206">US5091206</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">May 30, 1989</td><td class="patent-data-table-td patent-date-value">Feb 25, 1992</td><td class="patent-data-table-td ">Baxter Diagnostics Inc.</td><td class="patent-data-table-td ">Process for producing magnetically responsive polymer particles and application thereof</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5108933">US5108933</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Aug 4, 1989</td><td class="patent-data-table-td patent-date-value">Apr 28, 1992</td><td class="patent-data-table-td ">Immunicon Corporation</td><td class="patent-data-table-td ">Manipulation of colloids for facilitating magnetic separations</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5422279">US5422279</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jun 8, 1993</td><td class="patent-data-table-td patent-date-value">Jun 6, 1995</td><td class="patent-data-table-td ">Reference Diagnostics, Inc.</td><td class="patent-data-table-td ">Lipid fractionation</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5441635">US5441635</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Mar 10, 1993</td><td class="patent-data-table-td patent-date-value">Aug 15, 1995</td><td class="patent-data-table-td ">Asahi Kogaku Kogyo Kabushiki Kaisha</td><td class="patent-data-table-td ">Packing material for liquid chromatography</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5484701">US5484701</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jan 31, 1992</td><td class="patent-data-table-td patent-date-value">Jan 16, 1996</td><td class="patent-data-table-td ">E. I. Du Pont De Nemours And Company</td><td class="patent-data-table-td ">Method for sequencing DNA using biotin-strepavidin conjugates to facilitate the purification of primer extension products</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5508164">US5508164</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Oct 29, 1993</td><td class="patent-data-table-td patent-date-value">Apr 16, 1996</td><td class="patent-data-table-td ">Dekalb Genetics Corporation</td><td class="patent-data-table-td ">Isolation of biological materials using magnetic particles</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5512439">US5512439</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jul 6, 1994</td><td class="patent-data-table-td patent-date-value">Apr 30, 1996</td><td class="patent-data-table-td ">Dynal As</td><td class="patent-data-table-td ">Oligonucleotide-linked magnetic particles and uses thereof</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5523231">US5523231</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jun 2, 1994</td><td class="patent-data-table-td patent-date-value">Jun 4, 1996</td><td class="patent-data-table-td ">Amersham International Plc</td><td class="patent-data-table-td ">Method to isolate macromolecules using magnetically attractable beads which do not specifically bind the macromolecules</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/USRE35340">USRE35340</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Aug 13, 1993</td><td class="patent-data-table-td patent-date-value">Oct 1, 1996</td><td class="patent-data-table-td ">Asahi Kogaku Kogyo K.K.</td><td class="patent-data-table-td ">Homogeneous fluoroapatite particles</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="http://www.google.com/url?id=DhZEBAABERAJ&amp;q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DBE%26NR%3D686243A%26KC%3DA%26FT%3DD&amp;usg=AFQjCNHIg2lOOLWXo9Xk0u9pafE57kgbJA">BE686243A</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td "> </td><td class="patent-data-table-td citation-no-title">Title not available</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0162819A1?cl=en">EP0162819A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Feb 6, 1985</td><td class="patent-data-table-td patent-date-value">Nov 27, 1985</td><td class="patent-data-table-td ">Schröder, Ulf</td><td class="patent-data-table-td ">A method for in vitro diagnosis and a diagnostic agent</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0281390A2?cl=en">EP0281390A2</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Mar 2, 1988</td><td class="patent-data-table-td patent-date-value">Sep 7, 1988</td><td class="patent-data-table-td ">Gen-Probe Incorporated</td><td class="patent-data-table-td ">Polycationic supports for nucleic acid purification, separation and hybridization</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="http://www.google.com/url?id=DhZEBAABERAJ&amp;q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DJP%26NR%3D40408934A%26KC%3DA%26FT%3DD&amp;usg=AFQjCNELeizXyjPNpcSdjd-vkS9hc6btug">JP40408934A</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td "> </td><td class="patent-data-table-td citation-no-title">Title not available</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO1984001503A1?cl=en">WO1984001503A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Oct 17, 1983</td><td class="patent-data-table-td patent-date-value">Apr 26, 1984</td><td class="patent-data-table-td ">Coulter Electronics</td><td class="patent-data-table-td ">Magnetic separation using chelated magnetic ions</td></tr></table><div class="patent-section-footer">* Cited by examiner</div></div><div class="patent-section patent-tabular-section"><a id="npl-citations"></a><div class="patent-section-header"><span class="patent-section-title">Non-Patent Citations</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th colspan="3"class="patent-data-table-th">Reference</th></tr></thead><tr><td class="patent-data-table-td ">1</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Bitton et al., "<a href='http://scholar.google.com/scholar?q="Removal+of+Escherichia+coli+Bacteriophage+T7+by+Magnetic+Filtration%2C"'>Removal of Escherichia coli Bacteriophage T7 by Magnetic Filtration,</a>" Water Res., 8(8), 549-551 (1974); Chem. Abstr., 82, p. 278, Abstr. No. 115,953y (1974); only Abstract supplied.</td></tr><tr><td class="patent-data-table-td ">2</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Bitton et al., Removal of Escherichia coli Bacteriophage T7 by Magnetic Filtration, Water Res., 8(8), 549 551 (1974); Chem. Abstr., 82, p. 278, Abstr. No. 115,953y (1974); only Abstract supplied.</td></tr><tr><td class="patent-data-table-td ">3</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Flygare et al., "<a href='http://scholar.google.com/scholar?q="Magnetic+Aqueous+Two-phase+Separation+in+Preparative+Applications%2C"'>Magnetic Aqueous Two-phase Separation in Preparative Applications,</a>" Enzyme Microb. Biotech., 12(2), 95-103 (1990); Chem. Abstr., 112, p. 606, Abstr. No. 96880s (1990); only Abstract supplied.</td></tr><tr><td class="patent-data-table-td ">4</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Flygare et al., Magnetic Aqueous Two phase Separation in Preparative Applications, Enzyme Microb. Biotech., 12(2), 95 103 (1990); Chem. Abstr., 112, p. 606, Abstr. No. 96880s (1990); only Abstract supplied.</td></tr><tr><td class="patent-data-table-td ">5</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Munro et al., "<a href='http://scholar.google.com/scholar?q="Magnetic+Seeding+to+Aid+Recovery+of+Biological+Precipitates%2C"'>Magnetic Seeding to Aid Recovery of Biological Precipitates,</a>" Biotechnol. Letters, 3(6), 297-302 (1981); Chem. Abstr., 95, pp. 394-395, Abstr. No. 76474q (1981); both Abstract and publication supplied.</td></tr><tr><td class="patent-data-table-td ">6</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Munro et al., Magnetic Seeding to Aid Recovery of Biological Precipitates, Biotechnol. Letters, 3(6), 297 302 (1981); Chem. Abstr., 95, pp. 394 395, Abstr. No. 76474q (1981); both Abstract and publication supplied.</td></tr><tr><td class="patent-data-table-td ">7</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Warren, "<a href='http://scholar.google.com/scholar?q="New+Purification+Procedure+for+Biological+Vaccines+%28Adsorption+on+Magnetic+Iron+Oxides%29%2C"'>New Purification Procedure for Biological Vaccines (Adsorption on Magnetic Iron Oxides),</a>" Immunization Jap. Encephalitis Conf., Hammon (ed.), Williams &amp; Wilkins, Baltimore, MD, 1971, pp. 152-154; Chem. Abstr., 77, p. 308, Abstr. No. 92767w (1972); only Abstract supplied.</td></tr><tr><td class="patent-data-table-td ">8</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Warren, New Purification Procedure for Biological Vaccines (Adsorption on Magnetic Iron Oxides), Immunization Jap. Encephalitis Conf., Hammon (ed.), Williams &amp; Wilkins, Baltimore, MD, 1971, pp. 152 154; Chem. Abstr., 77, p. 308, Abstr. No. 92767w (1972); only Abstract supplied.</td></tr></table><div class="patent-section-footer">* Cited by examiner</div></div><div class="patent-section patent-tabular-section"><a id="forward-citations"></a><div class="patent-section-header"><span class="patent-section-title">Referenced by</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Citing Patent</th><th class="patent-data-table-th">Filing date</th><th class="patent-data-table-th">Publication date</th><th class="patent-data-table-th">Applicant</th><th class="patent-data-table-th">Title</th></tr></thead><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6193892">US6193892</a></td><td class="patent-data-table-td patent-date-value">Mar 3, 1999</td><td class="patent-data-table-td patent-date-value">Feb 27, 2001</td><td class="patent-data-table-td ">Promega Corporation</td><td class="patent-data-table-td ">Magnetic separation assembly and method</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6270970">US6270970</a></td><td class="patent-data-table-td patent-date-value">May 14, 1999</td><td class="patent-data-table-td patent-date-value">Aug 7, 2001</td><td class="patent-data-table-td ">Promega Corporation</td><td class="patent-data-table-td ">Mixed-bed solid phase and its use in the isolation of nucleic acids</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6284470">US6284470</a></td><td class="patent-data-table-td patent-date-value">Aug 24, 2000</td><td class="patent-data-table-td patent-date-value">Sep 4, 2001</td><td class="patent-data-table-td ">Promega Corporation</td><td class="patent-data-table-td ">Kits for cell concentration and lysate clearance using paramagnetic particles</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6310199">US6310199</a></td><td class="patent-data-table-td patent-date-value">May 14, 1999</td><td class="patent-data-table-td patent-date-value">Oct 30, 2001</td><td class="patent-data-table-td ">Promega Corporation</td><td class="patent-data-table-td ">By adsorbing to the target nucleic acid at an adsorption ph and releasing the target nucleic acid at a desorption ph which is higher than the adsorption ph; magnetic silia particles; glycidyl ligands; amino acid ligands; spacers</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6368800">US6368800</a></td><td class="patent-data-table-td patent-date-value">Dec 13, 1999</td><td class="patent-data-table-td patent-date-value">Apr 9, 2002</td><td class="patent-data-table-td ">Promega Corporation</td><td class="patent-data-table-td ">Kits for isolating biological target materials using silica magnetic particles</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6376194">US6376194</a></td><td class="patent-data-table-td patent-date-value">Jul 24, 2001</td><td class="patent-data-table-td patent-date-value">Apr 23, 2002</td><td class="patent-data-table-td ">Promega Corporation</td><td class="patent-data-table-td ">Complexing, releasing, calibration</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6673631">US6673631</a></td><td class="patent-data-table-td patent-date-value">Aug 20, 1999</td><td class="patent-data-table-td patent-date-value">Jan 6, 2004</td><td class="patent-data-table-td ">Promega Corporation</td><td class="patent-data-table-td ">Simultaneous isolation and quantitation of DNA</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6787307">US6787307</a></td><td class="patent-data-table-td patent-date-value">Nov 13, 2000</td><td class="patent-data-table-td patent-date-value">Sep 7, 2004</td><td class="patent-data-table-td ">Promega Corporation</td><td class="patent-data-table-td ">Lysate clearance and nucleic acid isolation using silanized silica matrices</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6806362">US6806362</a></td><td class="patent-data-table-td patent-date-value">Mar 20, 2001</td><td class="patent-data-table-td patent-date-value">Oct 19, 2004</td><td class="patent-data-table-td ">Promega Corporation</td><td class="patent-data-table-td ">pH dependent ion exchange matrix and method of use in the isolation of nucleic acids</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6870047">US6870047</a></td><td class="patent-data-table-td patent-date-value">Jan 10, 2001</td><td class="patent-data-table-td patent-date-value">Mar 22, 2005</td><td class="patent-data-table-td ">Roche Diagnostics Gmbh</td><td class="patent-data-table-td ">Magnetic pigment</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7078224">US7078224</a></td><td class="patent-data-table-td patent-date-value">Dec 30, 1999</td><td class="patent-data-table-td patent-date-value">Jul 18, 2006</td><td class="patent-data-table-td ">Promega Corporation</td><td class="patent-data-table-td ">Cell concentration and lysate clearance using paramagnetic particles</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7183002">US7183002</a></td><td class="patent-data-table-td patent-date-value">Mar 22, 2001</td><td class="patent-data-table-td patent-date-value">Feb 27, 2007</td><td class="patent-data-table-td ">Qiagen, Gmbh</td><td class="patent-data-table-td ">Porous ferro- or ferrimagnetic glass particles for isolating molecules</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7371830">US7371830</a></td><td class="patent-data-table-td patent-date-value">Jan 24, 2005</td><td class="patent-data-table-td patent-date-value">May 13, 2008</td><td class="patent-data-table-td ">Roche Diagnostics Gmbh</td><td class="patent-data-table-td ">Coated with pore-free outer glass layer comprised of boron oxide; core includes magnetite (Fe3O4) and Fe2O3; isolating nucleic acids by binding to surface</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7527929">US7527929</a></td><td class="patent-data-table-td patent-date-value">Jul 29, 2005</td><td class="patent-data-table-td patent-date-value">May 5, 2009</td><td class="patent-data-table-td ">Agencourt Bioscience Corporation</td><td class="patent-data-table-td ">Solid phase carriers having a first functional group which reversibly binds nucleic acids and a second functional group which selectively and reversibly binds the target nucleic acid species; quality; capillary electrophoresis; nucleotide sequencing, reverse transcription cloning and gene therapy</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7601491">US7601491</a></td><td class="patent-data-table-td patent-date-value">Feb 6, 2003</td><td class="patent-data-table-td patent-date-value">Oct 13, 2009</td><td class="patent-data-table-td ">Becton, Dickinson And Company</td><td class="patent-data-table-td ">Pretreatment method for extraction of nucleic acid from biological samples and kits therefor</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7727727">US7727727</a></td><td class="patent-data-table-td patent-date-value">Jan 26, 2009</td><td class="patent-data-table-td patent-date-value">Jun 1, 2010</td><td class="patent-data-table-td ">Becton Dickinson And Company</td><td class="patent-data-table-td ">Pretreatment method for extraction of nucleic acid from biological samples and kits therefor</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7922917">US7922917</a></td><td class="patent-data-table-td patent-date-value">Dec 7, 2006</td><td class="patent-data-table-td patent-date-value">Apr 12, 2011</td><td class="patent-data-table-td ">Qiagen Gmbh</td><td class="patent-data-table-td ">Porous ferro- or ferrimagnetic glass particles for isolating molecules</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8030034">US8030034</a></td><td class="patent-data-table-td patent-date-value">Dec 8, 2006</td><td class="patent-data-table-td patent-date-value">Oct 4, 2011</td><td class="patent-data-table-td ">Promega Corporation</td><td class="patent-data-table-td ">Nucleic acid purification with a binding matrix</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8039613">US8039613</a></td><td class="patent-data-table-td patent-date-value">Aug 28, 2009</td><td class="patent-data-table-td patent-date-value">Oct 18, 2011</td><td class="patent-data-table-td ">Promega Corporation</td><td class="patent-data-table-td ">Methods of purifying a nucleic acid and formulation and kit for use in performing such methods</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8129118">US8129118</a></td><td class="patent-data-table-td patent-date-value">May 11, 2005</td><td class="patent-data-table-td patent-date-value">Mar 6, 2012</td><td class="patent-data-table-td ">Roche Diagnostics Gmbh</td><td class="patent-data-table-td ">Magnetic glass particles, method for their preparation and uses thereof</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8202427">US8202427</a></td><td class="patent-data-table-td patent-date-value">Feb 24, 2011</td><td class="patent-data-table-td patent-date-value">Jun 19, 2012</td><td class="patent-data-table-td ">Qiagen Gmbh</td><td class="patent-data-table-td ">Porous ferro-or ferrimagnetic glass particles for isolating molecules</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8222397">US8222397</a></td><td class="patent-data-table-td patent-date-value">Aug 28, 2009</td><td class="patent-data-table-td patent-date-value">Jul 17, 2012</td><td class="patent-data-table-td ">Promega Corporation</td><td class="patent-data-table-td ">Methods of optimal purification of nucleic acids and kit for use in performing such methods</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8288169">US8288169</a></td><td class="patent-data-table-td patent-date-value">Mar 24, 2008</td><td class="patent-data-table-td patent-date-value">Oct 16, 2012</td><td class="patent-data-table-td ">Argylla Technologies</td><td class="patent-data-table-td ">Surface mediated self-assembly of nanoparticles</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8388908">US8388908</a></td><td class="patent-data-table-td patent-date-value">May 27, 2010</td><td class="patent-data-table-td patent-date-value">Mar 5, 2013</td><td class="patent-data-table-td ">Integenx Inc.</td><td class="patent-data-table-td ">Fluidic devices with diaphragm valves</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8394642">US8394642</a></td><td class="patent-data-table-td patent-date-value">Jun 7, 2010</td><td class="patent-data-table-td patent-date-value">Mar 12, 2013</td><td class="patent-data-table-td ">Integenx Inc.</td><td class="patent-data-table-td ">Universal sample preparation system and use in an integrated analysis system</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8426126">US8426126</a></td><td class="patent-data-table-td patent-date-value">Sep 30, 2004</td><td class="patent-data-table-td patent-date-value">Apr 23, 2013</td><td class="patent-data-table-td ">Applied Biosystems, Llc</td><td class="patent-data-table-td ">Modified surfaces as solid supports for nucleic acid purification</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8431340">US8431340</a></td><td class="patent-data-table-td patent-date-value">Oct 23, 2009</td><td class="patent-data-table-td patent-date-value">Apr 30, 2013</td><td class="patent-data-table-td ">Integenx Inc.</td><td class="patent-data-table-td ">DNA sequencing and genotyping, proteomics, pathogen detection, diagnostics and biodefense; devices for the interfacing of microchips to various types of modules</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8431390">US8431390</a></td><td class="patent-data-table-td patent-date-value">Nov 2, 2011</td><td class="patent-data-table-td patent-date-value">Apr 30, 2013</td><td class="patent-data-table-td ">Integenx Inc.</td><td class="patent-data-table-td ">Systems of sample processing having a macro-micro interface</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8476063">US8476063</a></td><td class="patent-data-table-td patent-date-value">Jun 15, 2010</td><td class="patent-data-table-td patent-date-value">Jul 2, 2013</td><td class="patent-data-table-td ">Integenx Inc.</td><td class="patent-data-table-td ">Microfluidic devices</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8497065">US8497065</a></td><td class="patent-data-table-td patent-date-value">Feb 13, 2009</td><td class="patent-data-table-td patent-date-value">Jul 30, 2013</td><td class="patent-data-table-td ">Life Technologies Corporation</td><td class="patent-data-table-td ">Methods and kits for extraction of DNA</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8512538">US8512538</a></td><td class="patent-data-table-td patent-date-value">May 23, 2011</td><td class="patent-data-table-td patent-date-value">Aug 20, 2013</td><td class="patent-data-table-td ">Integenx Inc.</td><td class="patent-data-table-td ">Capillary electrophoresis device</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8519119">US8519119</a></td><td class="patent-data-table-td patent-date-value">Sep 14, 2011</td><td class="patent-data-table-td patent-date-value">Aug 27, 2013</td><td class="patent-data-table-td ">Promega Corporation</td><td class="patent-data-table-td ">Methods of purifying a nucleic acid and formulation and kit for use in performing such methods</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8551714">US8551714</a></td><td class="patent-data-table-td patent-date-value">Feb 6, 2012</td><td class="patent-data-table-td patent-date-value">Oct 8, 2013</td><td class="patent-data-table-td ">Integenx Inc.</td><td class="patent-data-table-td ">Microfluidic devices</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8557518">US8557518</a></td><td class="patent-data-table-td patent-date-value">Jul 28, 2010</td><td class="patent-data-table-td patent-date-value">Oct 15, 2013</td><td class="patent-data-table-td ">Integenx Inc.</td><td class="patent-data-table-td ">Microfluidic and nanofluidic devices, systems, and applications</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8562918">US8562918</a></td><td class="patent-data-table-td patent-date-value">Dec 17, 2012</td><td class="patent-data-table-td patent-date-value">Oct 22, 2013</td><td class="patent-data-table-td ">Integenx Inc.</td><td class="patent-data-table-td ">Universal sample preparation system and use in an integrated analysis system</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8584703">US8584703</a></td><td class="patent-data-table-td patent-date-value">Nov 18, 2010</td><td class="patent-data-table-td patent-date-value">Nov 19, 2013</td><td class="patent-data-table-td ">Integenx Inc.</td><td class="patent-data-table-td ">Device with diaphragm valve</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8658360">US8658360</a></td><td class="patent-data-table-td patent-date-value">Sep 1, 2011</td><td class="patent-data-table-td patent-date-value">Feb 25, 2014</td><td class="patent-data-table-td ">Promega Corporation</td><td class="patent-data-table-td ">Nucleic acid purification with a binding matrix</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8672532">US8672532</a></td><td class="patent-data-table-td patent-date-value">Dec 18, 2009</td><td class="patent-data-table-td patent-date-value">Mar 18, 2014</td><td class="patent-data-table-td ">Integenx Inc.</td><td class="patent-data-table-td ">Microfluidic methods</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8697435">US8697435</a></td><td class="patent-data-table-td patent-date-value">Aug 30, 2010</td><td class="patent-data-table-td patent-date-value">Apr 15, 2014</td><td class="patent-data-table-td ">Mbio Diagnostics, Inc.</td><td class="patent-data-table-td ">Integrated sample preparation and analyte detection</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8748165">US8748165</a></td><td class="patent-data-table-td patent-date-value">Aug 21, 2012</td><td class="patent-data-table-td patent-date-value">Jun 10, 2014</td><td class="patent-data-table-td ">Integenx Inc.</td><td class="patent-data-table-td ">Methods for generating short tandem repeat (STR) profiles</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8763642">US8763642</a></td><td class="patent-data-table-td patent-date-value">Aug 20, 2011</td><td class="patent-data-table-td patent-date-value">Jul 1, 2014</td><td class="patent-data-table-td ">Integenx Inc.</td><td class="patent-data-table-td ">Microfluidic devices with mechanically-sealed diaphragm valves</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP1475387A2?cl=en">EP1475387A2</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Mar 18, 2004</td><td class="patent-data-table-td patent-date-value">Nov 10, 2004</td><td class="patent-data-table-td ">Bayer Healthcare LLC</td><td class="patent-data-table-td ">Method for preparing assay samples</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP1621618A1?cl=en">EP1621618A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Dec 30, 1999</td><td class="patent-data-table-td patent-date-value">Feb 1, 2006</td><td class="patent-data-table-td ">Promega Corporation</td><td class="patent-data-table-td ">Cell concentration and lysate clearance using paramagnetic particles</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2000070040A1?cl=en">WO2000070040A1</a></td><td class="patent-data-table-td patent-date-value">Dec 30, 1999</td><td class="patent-data-table-td patent-date-value">Nov 23, 2000</td><td class="patent-data-table-td ">Promega Corp</td><td class="patent-data-table-td ">Cell concentration and lysate clearance using paramagnetic particles</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2003046213A2?cl=en">WO2003046213A2</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Oct 25, 2002</td><td class="patent-data-table-td patent-date-value">Jun 5, 2003</td><td class="patent-data-table-td ">Merck Patent Gmbh</td><td class="patent-data-table-td ">Method for concentrating and detecting hiv</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2003076456A2?cl=en">WO2003076456A2</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Mar 7, 2003</td><td class="patent-data-table-td patent-date-value">Sep 18, 2003</td><td class="patent-data-table-td ">Caussette Mylene</td><td class="patent-data-table-td ">Hepatitis c virus replicon containing a reporter gene and a selectable marker gene</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2003091452A1?cl=en">WO2003091452A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Apr 22, 2003</td><td class="patent-data-table-td patent-date-value">Nov 6, 2003</td><td class="patent-data-table-td ">Arne Deggerdal</td><td class="patent-data-table-td ">Isolating nucleic acid</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2006077020A2?cl=en">WO2006077020A2</a></td><td class="patent-data-table-td patent-date-value">Jan 9, 2006</td><td class="patent-data-table-td patent-date-value">Jul 27, 2006</td><td class="patent-data-table-td ">Fraunhofer Ges Forschung</td><td class="patent-data-table-td ">Method for the specific or unspecific separation of cells and/or viruses from aqueous media and use thereof</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2007035750A1?cl=en">WO2007035750A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Sep 19, 2006</td><td class="patent-data-table-td patent-date-value">Mar 29, 2007</td><td class="patent-data-table-td ">Agencourt Bioscience Corp</td><td class="patent-data-table-td ">Method for isolating nucleic acids</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2009040444A1?cl=en">WO2009040444A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Sep 29, 2008</td><td class="patent-data-table-td patent-date-value">Apr 2, 2009</td><td class="patent-data-table-td ">Mole Genetics As</td><td class="patent-data-table-td ">Rna isolation method</td></tr></table><div class="patent-section-footer">* Cited by examiner</div></div><div class="patent-section patent-tabular-section"><a id="classifications"></a><div class="patent-section-header"><span class="patent-section-title">Classifications</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th"> </th><th class="patent-data-table-th"> </th></tr></thead><tr><td class="patent-data-table-td ">U.S. Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=DhZEBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc536/defs536.htm&usg=AFQjCNHex3TR9tihVxBKQnsQg6n8YmdVYg#C536S025400">536/25.4</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=DhZEBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc435/defs435.htm&usg=AFQjCNFivWgFr8pvtdk7qYLW9R7yxFP7Dg#C435S270000">435/270</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=DhZEBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc252/defs252.htm&usg=AFQjCNE-tjgBAJMY274ZgpNHhahuJ7YOZw#C252S062540">252/62.54</a></span></td></tr><tr><td class="patent-data-table-td ">International Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=DhZEBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=C12S0003200000">C12S3/20</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=DhZEBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=C07K0001340000">C07K1/34</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=DhZEBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=C12N0001020000">C12N1/02</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=DhZEBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=C07K0001300000">C07K1/30</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=DhZEBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=B03C0001010000">B03C1/01</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=DhZEBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=C12N0007020000">C12N7/02</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=DhZEBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=C12N0015100000">C12N15/10</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=DhZEBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=C07H0001060000">C07H1/06</a></span></td></tr><tr><td class="patent-data-table-td ">Cooperative Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=DhZEBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=C07K1/30">C07K1/30</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=DhZEBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=C12N7/00">C12N7/00</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=DhZEBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=C12N1/02">C12N1/02</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=DhZEBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=C07H1/06">C07H1/06</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=DhZEBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=B03C1/01">B03C1/01</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=DhZEBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=C12N15/1013">C12N15/1013</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=DhZEBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=C12N2795/14151">C12N2795/14151</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=DhZEBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=C07K1/34">C07K1/34</a></span></td></tr><tr><td class="patent-data-table-td ">European Classification</td><td class="patent-data-table-td "><span class="nested-value">C12N7/00</span>, <span class="nested-value">C07K1/34</span>, <span class="nested-value">C07K1/30</span>, <span class="nested-value">C12N1/02</span>, <span class="nested-value">C07H1/06</span>, <span class="nested-value">B03C1/01</span>, <span class="nested-value">C12N15/10A2D</span></td></tr></table><div class="patent-section-footer"></div></div><div class="patent-section patent-tabular-section"><a id="legal-events"></a><div class="patent-section-header"><span class="patent-section-title">Legal Events</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Date</th><th class="patent-data-table-th">Code</th><th class="patent-data-table-th">Event</th><th class="patent-data-table-th">Description</th></tr></thead><tr><td class="patent-data-table-td patent-date-value">Sep 1, 2009</td><td class="patent-data-table-td ">RR</td><td class="patent-data-table-td ">Request for reexamination filed</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20090615</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">May 18, 2009</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">GE HEALTHCARE UK LIMITED, GREAT BRITAIN</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:GE HEALTHCARE LIMITED;REEL/FRAME:022694/0403</span></div><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20090127</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">May 15, 2009</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">GE HEALTHARE LIMITED, GREAT BRITAIN</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">CHANGE OF NAME;ASSIGNOR:AMERSHAM INTERNATIONAL PLC;REEL/FRAME:022689/0308</span></div><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20050825</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">May 12, 2009</td><td class="patent-data-table-td ">B1</td><td class="patent-data-table-td ">Reexamination certificate first reexamination</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">THE PATENTABILITY OF CLAIMS 1-4 IS CONFIRMED. CLAIMS 5-8 WERE NOT REEXAMINED.</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Apr 28, 2009</td><td class="patent-data-table-td ">FPAY</td><td class="patent-data-table-td ">Fee payment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Year of fee payment: </span><span class="nested-value">12</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">May 20, 2008</td><td class="patent-data-table-td ">RR</td><td class="patent-data-table-td ">Request for reexamination filed</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20080304</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Apr 28, 2005</td><td class="patent-data-table-td ">FPAY</td><td class="patent-data-table-td ">Fee payment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Year of fee payment: </span><span class="nested-value">8</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Apr 5, 2001</td><td class="patent-data-table-td ">FPAY</td><td class="patent-data-table-td ">Fee payment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Year of fee payment: </span><span class="nested-value">4</span></div></td></tr></table><div class="patent-section-footer"></div></div><div class="modal-dialog" id="patent-images-lightbox"><div class="patent-lightbox-controls"><div class="patent-lightbox-rotate-controls"><div class="patent-lightbox-rotation-text">Rotate</div><div class="rotate-icon rotate-ccw-icon"></div><div class="rotate-icon rotate-cw-icon"></div></div><div class="patent-lightbox-index-counter"></div><a class="patent-lightbox-fullsize-link" target="_blank">Original Image</a><div class="patent-drawings-control patent-drawings-next"><img class="patent-drawings-button-img"src="/googlebooks/images/kennedy/page_right.png" alt="Next page"width="21" height="21" /></div><div class="patent-drawings-control patent-drawings-prev"><img class="patent-drawings-button-img"src="/googlebooks/images/kennedy/page_left.png" alt="Previous page"width="21" height="21" /></div></div><div class="modal-dialog-content"><div class="patent-lightbox-image-holder"><div class="patent-lightbox-placeholder"></div></div></div></div><script>_OC_initPatentsAtb({image_not_available_html: " Image not available"});</script></div></div></div></td></tr></table><script>(function() {var href = window.location.href;if (href.indexOf('?') !== -1) {var parameters = href.split('?')[1].split('&');for (var i = 0; i < parameters.length; i++) {var param = parameters[i].split('=');if (param[0] == 'focus') {var elem = document.getElementById(param[1]);if (elem) {elem.focus();}}}}})();</script><script>_OC_addFlags({LockSrc:"/books/javascript/lock_8a2b04e7bf975d5171d8e4c0b6365c7a.js", Host:"http://www.google.com/", IsBooksRentalEnabled:1, IsWebstoreDisplayCaseEnabled:1, IsObfuscationEnabled:1, IsBrowsingHistoryEnabled:1, IsWebReaderSvgEnabled:0, IsGeoLayerEnabled:1, IsImageModeNotesEnabled:1, IsCopyMenuItemEnabled:1, IsGiftingEnabled:0, IsWebReaderUniversalPaginatorEnabled:0, IsOfflineBubbleEnabled:1, IsReaderEnabledForPlayRequests:1, IsFutureOnSaleVolumesEnabled:1, IsOfflineRestrictedCopyEnabled:1, IsBooksUnifiedLeftNavEnabled:1, IsRestrictedCopyEnabled:1, IsZipitFolderCollectionEnabled:1, IsEndOfSampleRecommendationsEnabled:1, IsRatingsOnBookcardsEnabled:1, IsAdsDisabled:0, IsIframePageDisplayEnabled:0, IsEmbeddedMediaEnabled:1, IsImageModeAnnotationsEnabled:1, IsMyLibraryGooglePlusEnabled:1, IsImagePageProviderEnabled:0, IsBookcardListPriceSmall:0, IsInternalUser:0, IsBooksShareButtonEnabled:0, IsPreOrdersEnabled:0, IsDisabledRandomBookshelves:0, WebstoreDisplayCasePosition:3});_OC_Run({"enable_p13n":false,"add_vol_to_collection_base_url":"http://www.google.com/patents?op=add\u0026sig=ACfU3U3KXfR47ZkGSEZFjLYtiH-sYuRFcQ\u0026id=DhZEBAABERAJ","remove_vol_from_collection_base_url":"http://www.google.com/patents?op=remove\u0026sig=ACfU3U24ZF2S-9RRpAaMBx_wNo9-k4LJbg\u0026id=DhZEBAABERAJ","logged_in":false,"p13n_save_user_settings_url":"http://www.google.com/patents?op=edit_user_settings\u0026sig=ACfU3U0zefPySZDj8UKGsIJtD3ATFEYxGg","is_cobrand":false,"sign_in_url":"https://www.google.com/accounts/Login?service=\u0026continue=http://www.google.com/patents%3Fhl%3Den\u0026hl=en","is_play_enabled":true}, {"volume_id":"","is_ebook":true,"volumeresult":{"has_flowing_text":false,"has_scanned_text":true,"can_download_pdf":false,"can_download_epub":false,"is_pdf_drm_enabled":false,"is_epub_drm_enabled":false,"download_pdf_url":"http://www.google.com/patents/download/Precipitating_polymers.pdf?id=DhZEBAABERAJ\u0026output=pdf\u0026sig=ACfU3U3tLW2RqXRI9JYP9-Vn0KzmnjQ1mg"},"sample_url":"http://www.google.com/patents/reader?id=DhZEBAABERAJ\u0026printsec=frontcover\u0026output=reader\u0026source=gbs_atb_hover","is_browsable":true,"is_public_domain":true}, {});</script><div id="footer_table" style="font-size:83%;text-align:center;position:relative;top:20px;height:4.5em;margin-top:2em"><div style="margin-bottom:8px"><a href=http://www.google.com/><nobr>Google&nbsp;Home</nobr></a> - <a href=//www.google.com/patents/sitemap/><nobr>Sitemap</nobr></a> - <a href=http://www.google.com/googlebooks/uspto.html><nobr>USPTO Bulk Downloads</nobr></a> - <a href=/intl/en/privacy/><nobr>Privacy Policy</nobr></a> - <a href=/intl/en/policies/terms/><nobr>Terms of Service</nobr></a> - <a href=https://support.google.com/faqs/answer/2539193?hl=en><nobr>About Google Patents</nobr></a> - <a href="http://www.google.com/tools/feedback/intl/en/error.html" onclick="try{_OC_startFeedback({productId: '72792',locale: 'en'});return false;}catch(e){}"><nobr>Send Feedback</nobr></a></div><span>Data provided by IFI CLAIMS Patent Services</span><br><span >&copy;2012 Google</span></div> <script type="text/javascript">var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));</script><script type="text/javascript">var pageTracker = _gat._getTracker("UA-27188110-1");pageTracker._setCookiePath("/patents/");pageTracker._trackPageview();</script> </body></html>